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ABSTRACT 
 
In the search for alternative non-metabolizable inducers in the L-rhamnose promoter system, the 
synthesis of fifteen 6-deoxyhexoses from L-rhamnose demonstrates the value of synergy between 
biotechnology and chemistry. The readily available 2,3-acetonide of rhamnonolactone allows 
inversion of configuration at C4 and/or C5 of rhamnose to give 6-deoxy-D-allose, 6-deoxy-D-gulose 
and 6-deoxy-L-talose. Highly crystalline 3,5-benzylidene rhamnonolactone gives easy access to L-
quinovose [6-deoxy-L-glucose], L-olivose and rhamnose analogue with C2 azido, amino and 
acetamido substituents. Electrophilic fluorination of rhamnal gives a mixture of 2-deoxy-2-fluoro-L-
rhamnose and 2-deoxy-2-fluoro-L-quinovose. Biotechnology provides access to 6-deoxy-L-altrose and 
1-deoxy-L-fructose. 
 
KEY WORDS: rhamnose operon, rhamnonolactone, 6-deoxyhexose, rare sugar 
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INTRODUCTION  
 
In biotechnology, control over gene expression is often useful, such as in the production of proteins of 
interest. This is typically achieved by assembling a DNA construct in which the gene of interest is 
placed under the control of a promoter (a regulatory DNA sequence) which responds to a known 
external stimulus. Numerous inducible gene expression systems have been reported, exploiting 
inducible promoters which respond to natural or synthetic stimuli such as sugars, antibiotics and 
metals.[1] L-Rhamnose [6-deoxy-L-mannose] is readily metabolized by E. coli[2] and the metabolism of 
L-rhamnose is precisely controlled. L-Rhamnose works as inducer of the operon encoding the 
enzymes required for its metabolism, rhaBAD.[3] The L-rhamnose promoter system, PrhaBAD, is used 
extensively for the heterologous expression of many genes of interest in E. coli and other bacteria.[4] 
Its many advantages over alternative promoter systems include: non-leaky basal expression, titratable 
concentration-dependent expression and the ability to achieve higher levels of expression.[5] However, 
due to L-rhamnose metabolism and its auto-repression of the PrhaBAD promoter,[6] induction is transient, 
which limits its application. This system could be improved by the development of a non-
metabolizable analogue of L-rhamnose, an approach which has been developed for only a few other 
inducible expression systems.[7] No 6-deoxyhexose analogues have been tested for this purpose 
previously. 
 
The chemotherapeutic potential of interfering with L-rhamnose metabolic pathways in bacteria and in 
plants has long been recognized, and is safe because L-rhamnose has no role in mammalian 
metabolism.[ 8] Synthetic inducers/antagonists of the rhamnose operon might also be useful as 
antimicrobials, targeting pathogens requiring rhamnose-incorporation into their cell walls for survival. 
Control or suppression of expression of the genes encoding rhamnose metabolic enzymes may allow 
control of biosynthesis of TDP-rhamnose and thus of cell wall construction of a number of 
pathogens.[ 9 ] For example, a rhamnose inducible promoter was reported to be essential to 
Burkholderia cenocepacia.[10] Other L-rhamnose metabolic enzymes, such as L-rhamnosidases and L-
rhamnose isomerase, are also potential targets. Iminosugars affecting rhamnose processing enzymes 
may have potential as antibiotics.[11] The identification of synthetic inducers or antagonists of the L-
rhamnose metabolic pathway will be valuable tools for biotechnology.  
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Scheme 1: Strategy for synthesis of rhamnose mimics  
 
A recent study, which evaluated the effect of some 35 analogues of rhamnose on the operon, required 
access to 6-deoxyhexoses. [12] This paper describes the conversion of L-rhamnose 1, the cheapest 6-
deoxyhexose, [13] into 15 isomers and other analogues of rhamnose as free sugars by four different 
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strategies [Scheme 1]. Nucleophilic substitution of either pyranose or furanose derivatives of 
rhamnose[14] is easy neither to set up the precursor nor to perform SN2 displacements of sulfonates. 
However efficient SN2 reactions in rhamnonolactones can allow isomerization at C5, C4 and C2. The 
2,3-acetonide of rhamnonolactone 2 is readily available from L-rhamnose in multigram scale by a 
well-established procedure. [15 ] Lactone 2 allows access to the 3 diastereomeric lactols 3-5 as 
intermediates in the synthesis of 6-deoxy-D-gulose 6, 6-deoxy-D-allose 7 and 6-deoxy-L-talose 8 
(strategy A). Unlike many lactone acetonides, 2 is not crystalline and is usually contaminated with the 
corresponding 3,5-acetonide. The highly crystalline benzylidene lactone 9, with only C2 OH free, was 
prepared from L-rhamnose on a 50 g scale by a reported procedure (strategy B). [16] High yield 
nucleophilic substitution of the epimeric manno- 10 and gluco- 11 C2 triflates allowed the syntheses 
of the epimer at C2 L-quinovose 12, the dideoxy hexose L-olivose 13 and both epimers of analogues 
with nitrogen introduced at C2 14; 2-nitrogen substituted analogues are also useful building blocks for 
the synthesis of bioactive glycoconjugates. [17] It was not possible to introduce fluorine at C2 by an 
SN2 reaction; strategy C uses diacetyl rhamnal 15 for the non-stereoselective introduction of 
electrophilic fluorine to allow access to the 2-fluoro analogues of rhamnose 16 and quinovose 17. It is 
not easy to access C3 of rhamnonolactone (or rhamnose) chemically; [18] however, a highly efficient 
biotechnological synthesis of the C3 epimer 18 allows the preparation of multigram quantities 
(strategy D). Rhamnose may also be converted to 19 where the anomeric hydroxyl group has been 
transposed from C1 to C5. Thus a combination of biotechnology and chemistry has allowed the 
preparation of some 15 analogues of rhamnose as free sugars for evaluation as inducers of the 
rhamnose operon. 
 
SYNTHESIS 
 
A Stereoisomers at C4 and C5 of rhamnose from 2,3-O-isopropylidene rhamnonolactone 2 
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Scheme 2: (i) Dess-Martin periodinane, CH2Cl2 (ii) NaBH4, MeOH, rt (iii) DIBALH, CH2Cl2, -78 oC, 
(iv) DOWEX® 50WX8-100 (H+ form), H2O, rt (v) MeSO2Cl, DMAP, pyridine, 0 oC (vi) KOH, 
H2O:1,4-dioxane, rt (vii) (CF3SO2)2O, pyridine, CH2Cl2 (viii) CF3COONa, pentanone  
 
The acetonide of rhamnonolactone 2 allowed easy access to three diastereomeric lactones at C4 and 
C5 22, 24 and 26 [Scheme 2]. There are very few examples of SN2 reactions[19] at C5 of 2. The 
difficulty probably arises from the extra steric hindrance because of the cis-relationship of the 
isopropylidene protecting group and the C4-side chain; SN2 displacements at C5 of the C4-epimeric 
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talono-lactone 24, where there is a corresponding trans arrangement, are efficient. [20] All attempts to 
use oxygen nucleophiles [acetate or trifluoroacetate in DMF, butanone or pentanone] on either the 
mesylate 23 or the corresponding triflate gave no indication of the formation of the gulo-epimer 22. 
Accordingly, inversion of configuration at C5 was achieved by Dess-Martin oxidation of 2 in 
dichloromethane to give the crystalline ketone 21 (77%). Reduction of 21 with sodium borohydride ar 
room temperature showed little diastereoselectivity to give crystalline 22[21] (54%) and the D-gulo-
lactone 2 in a 1.5:1 ratio. No improvement in the ratio was found at lower temperatures or use of 
cyanoborohydride and other conditions led to competitive reduction of the lactone; a similar lack 
diastereoselectivity has been found in analogous systems. [22] The two lactones 2 and 22 were readily 
separable by chromatography. Reduction of 22 with diisobutylaluminum hydride (DIBALH) in 
dichloromethane afforded the lactols 3 (75%). In the reduction of 2,3-protected lactones, no attempts 
were made to analyze the ratio of 2,3-O-isopropylidene pyranoses and furanoses formed. Acid ion 
exchange catalyzed hydrolysis of the lactols at room temperature gave 6-deoxy-D-gulose 6[23], a syrup, 
(93%) predominantly as the β-pyranose form. 
 
Esterification of the free alcohol in 2 with mesyl chloride in pyridine gave the mesylate 23 (83%); 
treatment of 23 with aqueous potassium hydroxide in 1,4-dioxane caused inversion of configuration at 
both C4 and C5 by Payne rearrangements[24] to form the D-allono-lactone 24 (79%). Nucleophilic 
displacement at C5 of the allono-lactone 24 where the side chain is trans to the isopropylidene 
protecting group was efficient. Thus reaction of 24 with triflic anhydride in dichloromethane in the 
presence of pyridine gave the corresponding triflate 25 which, with sodium trifluoroacetate in 
pentanone at room temperature followed by work-up with methanol, [25] gave the talono-lactone 26 in 
70% yield. DMF is not an appropriate solvent since the solvent competes with trifluoroacetate as a 
nucleophile; the mesylate of 24 did not give SN displacement by trifluoroacetate.  
 
An identical two-step procedure for the reduction and hydrolysis of the protected allono- 24 and 
talono- 26 lactones gave 6-deoxy-D-allose 7[26] and 6-deoxy-L-talose 8[27], in overall yields of 83% 
and 72%, via the lactols 4 and 5 respectively.  
 
For the rhamnose operon assays, it was very important to establish that there was no contamination of 
6-deoxy-D-gulose 6 with rhamnose arising from incomplete separation of 2 and 22 in the reduction of 
ketone 21. Accordingly, an alternative approach to 6-deoxy-gulonolactone 22 by a double inversion 
of C4 and C5 of the talono-lactone 26 was investigated. Sequential formation of the mesylate 27 from 
26, followed by treatment with aqueous potassium, hydroxide gave 22 in 76% which was identical to 
that prepared from the reduction of the ketone 21. A sample of 6-deoxy-D-gulose 6 by this route gave 
an identical response in the rhamnose operon experiments to that derived from the ketone; [12] this 
established that there was no contamination with rhamnose in the synthesis via 21. 
 
B 2-Substituted rhamnose analogues from 3,5-O-benzylidene rhamnonolactone 9 
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Scheme 3:  (i) (CF3SO2)2O, pyridine, THF, -20 oC, 95% (ii) CF3COOCs, butanone, 60 oC, 4 h, 90% 
(iii) TBDMSCl, imidazole, DMF, 71% (iv) DIBALH, CH2Cl2, -78 oC, 1 h, 88% (v) DOWEX® 
50WX8-200 (H+ form), H2O, rt, 15 h, 100% (vi) LiI:3H2O, butanone, 60 oC, 16 h, 74% (vii) DIBALH, 
CH2Cl2, -78 oC, 3 h, 96% (viii) DOWEX® 50WX8-200 (H+ form), H2O, rt, 18 h, 100% 
 
The highly crystalline benzylidene lactone 9 was directly obtained from rhamnose on a 50 g scale as 
previously described. [28] Esterification of the C2-OH group in 9 with triflic anhydride in THF 
afforded the triflate 10[16] which is an ideal intermediate for SN2 reactions at C2 of rhamnose. 
Although the crude triflate 10 may be used directly in subsequent reactions, 10 is a stable triflate 
which can be purified by column chromatography. For the preparation of L-quinovose [6-deoxy-L-
glucose] 12, reaction of 10 with cesium trifluoroacetate in butanone[29] gave the inverted alcohol 2816 
(90%) [Scheme 3]. Attempts to reduce 28 directly gave complex mixtures but prior protection of 28 
with TBDMS chloride in DMF in the presence of imidazole afforded the TBDMS ether 29 (71%); 
DIBALH reduction of the fully protected lactone 29 formed the protected lactols 30 (88%). Removal 
of the silyl and benzylidene protecting groups in 30 by ion exchange gave L-quinovose 12[30] (100%) 
with an identical 1H NMR spectrum to that of an authentic sample of D-quinovose [see SI].  
 
Treatment of the triflate 10 with lithium iodide hydrate in butanone gave the iodide 31 by rapid SN2 
displacement of the triflate which underwent further attack by iodide to give iodine[31] and the 
deoxygenated lactone 32 (74%). Reduction of 32 by DIBALH in dichloromethane afforded the lactols 
33 (96%) which on hydrolysis by acid ion exchange resin gave L-olivose 13[32] (100%). 
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Scheme 4: (i) (CF3SO2)2O, pyridine, THF, -20 oC, 95% (ii) NaN3, DMF, -40 oC, 75%  (iii) DIBALH, 
CH2Cl2, -78 oC, 3 h, 84%  (iv) see text 85% 36 from 10 (v) (CF3SO2)2O, pyridine, THF, -20 oC (vi) 
NaN3, DMF, -40 oC, 70% 36 and 24% 34 [over two steps] (vii) DIBALH, CH2Cl2, -78 oC, 3 h, 87% 
 
In a number of cases it has been established that azide displacement of a triflate at C2 of a lactone 
may result in isolation of the azide with either retention or inversion of configuration. [25,33] For the 
preparation of C2 nitrogen derivatives of rhamnose and quinovose, high yield SN2 substitution of the 
		 6	
triflate 10 with sodium azide in DMF gave the kinetic gluco-azide 34 with inversion or the 
thermodynamic manno-azide 36 with retention, respectively [Scheme 4]. Reaction of the stable 
triflate 10 with sodium azide in DMF at -40 °C formed the inverted gluco-azide 34 (75%). After 
column purification, the gluco-azide 34 was reduced by DIBALH in dichloromethane to the lactols 35 
(84%).  When the SN2 reaction was conducted at room temperature, 10 formed the thermodynamic 
manno-azide 36 (85%). The initially formed 34 was converted to the more stable all cis-azide 36 
under the reaction conditions. The two azides were readily distinguishable by TLC and easily 
separable by column chromatography. The triflate 11 derived from the gluco-alcohol 28 was less 
stable than the manno-triflate 10. When crude triflate 11 in DMF was treated with sodium azide at -
20 °C, the manno-azide 36 (70%) was isolated together with the less stable gluco-azide 34 (24%); 
there is competition between azide displacement to give 36 (70%) and epimerization of triflate 11 to 
the more stable triflate 10 which then forms the less stable azide 34 (24%). Reduction of 36 with 
DIBALH in dichloromethane gave the manno-lactols 37 (87%). After the reduction, there was no 
indication of any epimerization of the gluco- 35 to the manno- 37 lactols.  
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Scheme 5: (i) DOWEX® 50WX8-200 (H+ form), H2O, rt (ii) H2, 10% Pd/C, HCl (iii) H2, 10% Pd/C, 
Ac2O, (iv) DOWEX® 50WX8-200 (H+ form), H2O 
 
Hydrolysis of the protected gluco-lactols 35 by acid ion exchange resin gave the quinovose azide 38 
(99%) [Scheme 5]. Hydrogenation of 38 in the presence of palladium on carbon and hydrochloride 
acid afforded the hydrochloride salt of 2-amino-2,6-dideoxy-L-glucose 39[34] (98%). Hydrogenation of 
the azide 35 in the presence of acetic anhydride and palladium in ethyl acetate/1,4-dioxane gave the 
protected gluco-acetamide 40 (74%). Removal of the benzylidene acetal in 40 by DOWEX-catalysed 
hydrolysis in aqueous ethanol afforded acetamido-quinovose 41[34] (90%). Identical procedures on the 
rhamno-azide 37 gave the azido- 42 (95%), amino- 43[34] (100%) and acetamido- 45 (80% from 37) 
rhamnose analogues in equally high yields.  
 
C 2-Deoxy-2-fluoro-L-rhamnose 16 and 2-Deoxy-2-fluoro-L-quinovose 17 from 3,4-di-O-acetyl 
rhamnal 
 
It was not possible either to displace the triflates in 10 by any of a number of nucleophilic sources of 
fluoride (including TASF, TBAF and CsF) or to introduce fluorine directly by reaction of the alcohol 
9 with DAST[35] or Xtalfluor[36].  
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Scheme 6: (i) SelectFluor, water, MeCN; then Ac2O in pyridine, 27% of pure 46β (ii) CF3COOH, H2O, 100% 
(iii) CF3COOH, H2O, 100% (mixture of free sugars), then pure 17 was isolated by preparative HPLC 
 
Accordingly, treatment of diacetylrhamnal 15 with SelectFluor in aqueous acetonitrile[37] followed 
by acetylation with acetic anhydride in pyridine during the workup caused electrophilic fluorination to 
give a mixture of the four sugar triacetates 46α/β and 47  [Scheme 6] with little stereoselectivity. One 
of the 4 triacetates, the β-fluoro-rhamnose 46β, was isolated as a pure crystalline solid. Hydrolysis of 
46β gave a pure sample of previously unknown 2-deoxy-2-fluoro-rhamnose 16 (27% overall yield) 
for biological evaluation. Hydrolysis of the mixture of 46α and 47α/β gave a mixture of fluoro-
rhamnose 16 and fluoro-quinovose 17 (38% yield); a pure sample of fluoro-quinovose 17 was 
obtained by preparative HPLC. 
 
D 1-Deoxy-L-fructose and 6-deoxy-L-altrose from rhamnose by biotechnology 
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Scheme 7: (i) H2, Raney Ni, H2O (ii) IK7 (iii) RI (iv) DTE (v) AI 
 
The biotechnology of Izumoring[38] allows access to substantial amounts of rare deoxy sugars from 
rhamnose in water without the need for any protection. Hydrogenation of rhamnose 1 in the presence 
of Raney nickel gave L-rhamnitol 48 (96%) [Scheme 7]. Oxidation of the (4S,5S) diol in 48 by 
Enterobacter aerogenes IK7 (IK7) afforded 1-deoxy-L-fructose 19; 37 g of 19 were obtained by direct 
crystallization of the crude oxidation product from 50 g of rhamnose 1.[39] Longer times of the 
reaction of 48 with IK7 gave oxidation of the (2S,3S) diol to form rhamnulose [6-deoxy-L-fructose] 
49 (10%);[41] 49 was also be obtained by L-rhamnose isomerase (RI) equilibration with 1. [30] D-
Tagatose-3-epimerase (DTE) equilibrates all C3 epimeric pairs of deoxyketoses[40] and equilibrated 49 
at C3 to give 6-deoxy-L-psicose 50.41 Reaction of 50 with L-arabinose isomerase (AI) afforded 6-
deoxy-L-altrose 18 allowing the ready preparation of 10 g of 18. 
 
NMR analysis of synthetic free 6-deoxy-hexoses 
 
1. 6-Deoxy-D-gulose 6 
		 8	
 
Table 1: 1H and 13C NMR data of 6-deoxy-D-gulose 6 (D2O), α-py:β-py = 1:10 
  C1 C2 C3 C4 C5 C6 
α pyranose 1H /J 5.11a/3.0b 3.88/3.0/3.3 4.01/3.3/4.0 3.75/4.0/1.0 4.37/1.0/6.6 1.21/6.6 
13C 91.9 63.8 70.0 70.6 61.5 13.8 
β pyranose 1H/J 4.85/8.3 3.57/8.3/3.2 4.07/3.2/3.2 3.62/3.2/0.6 4.10/0.6/6.5 1.22/6.5 
13C 92.8 68.0 70.4 71.0 68.4 14.3 
a: ppm; b: Hz. 
 
The synthesis and characterization, but not the NMR analysis, of 6-deoxy-D-gulose 6 has been 
reported. [23] 1H and 13C NMR spectra of 6 in D2O, pH=8.0, showed two spin-systems [Table 1], 
confirmed as pyranose forms by the HMBC correlations between C1 and H5 (D-gulose also exists 
mainly in the pyranose form[42]). The α and β pyranose anomers could be identified by the magnitude 
of coupling constant of anomeric proton (J1,2 of β anomer was 8.3 Hz because of the trans-diaxial 
configuration; J1,2 of α anomer was 3.0 Hz) and  were present in an α-pyranose:β-pyranose ratio of 
1:10.  
 
2. 6-Deoxy-L-talose 8 
 
Table 2: 1H and 13C NMR data of 6-deoxy-L-talose 8 (D2O), α-py:β-py:α-fu:β-fu = 1.00:0.72:0.36:0.14 
  C1 C2 C3 C4 C5 C6 
α pyranose 1H /J 5.21a/1.3b 3.80/1.3/3.2 3.91/3.2/3.2 3.74/3.2/1.0 4.17/1.0/6.7 1.24/6.7 
13C 95.3 71.0 66.0 72.8 67.6 16.4 
β pyranose 1H/J 4.77/1.1 3.85/1.1/3.3 3.75/3.3/3.3 3.66/3.3/1.0 3.69/1.0/6.5 1.27/6.5 
13C 94.6 71.8 69.3 71.7 71.9 16.2 
α furanose 1H /J 5.23/1.6 3.97/1.6/4.9 4.20/4.9/6.4 3.71/6.4/6.4 3.83/6.4/6.3 1.23/6.3 
13C 101.3 76.0 71.7 86.4 69.5 18.7 
β furanose 1H /J 5.35/2.6/1.3 4.08/nac 4.08/na 3.90/na 3.84/na 1.22/6.4 
13C 96.8 71.6 71.3 87.1 67.9 19.0 
a: ppm; b: Hz; c: can not be assigned due to overlaps or weak signals.	
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Figure 1: Key ROESY correlations of 6-deoxy-α-L-talopyranose and 6-deoxy-β-L-talopyranose 
 
1H and 13C NMR spectra of 6-deoxy-L-talose 8 in D2O, pH=7.8, showed four spin-systems [Table 2], 
confirmed as the pyranose and furanose forms by the HMBC correlations between C1 and H5 
(pyranose) and H4 (furanose). The α- and β-anomers of the pyranose forms of 8 were identified from 
the ROESY spectra, the H1 of the β-anomer showing strong correlations with H3 and H5 whereas the 
H1 of the α-anomer only showed a strong correlation with H2 [Figure 1]. The furanose forms were 
more difficult to analyze. The β-anomer was tentatively assigned on the basis of a stronger H1 to H2 
ROESY correlation (SI). In addition, the 13C data in this study agree with a previous report. [43] 
 
3. 6-Deoxy-D-allose 7 
 
Table 3: 1H and 13C NMR data of 6-deoxy-D-allose 7 (D2O), α-py:β-py:α-fu:β-fu = 0.11:1.00:0.03:0.04 
  C1 C2 C3 C4 C5 C6 
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α pyranose 1H /J 5.08a/3.4b 3.70/3.4/3.4 4.12/nac 3.36/na 4.04/9.4/6.4 1.26/6.4 
13C 93.4 68.0 72.1 72.3 63.5 17.2 
β pyranose 1H/J 4.85/8.3 3.40/8.3/3.0 4.12/3.0/2.8 3.36/2.8/9.8 3.82/9.8/6.3 1.24/6.3 
13C 93.9 72.1 71.7 72.9 70.1 17.6 
α furanose 1H /J 5.35/4.2 4.04/na 4.16/5.9/3.9 4.00/3.9/3.8 3.93/na 1.20/6.7 
13C 96.6 71.8 69.4 87.8 67.6 17.9 
β furanose 1H /J 5.22/2.3 3.94/na 4.30/5.2/5.2 3.82/na 3.93/na 1.22/6.7 
13C 101.1 76.1 70.7 86.3 68.1 17.9 
a: ppm; b: Hz; c: can not be assigned due to overlaps or weak signals. 
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Figure 2: 6-Deoxy-β-D-allopyranose in a 4C1 conformation and 6-deoxy-α-L-talofuranose and 6-deoxy-β-D-
allofuranose 
 
The NMR data of 6-deoxy-β-D-allopyranose has been previously reported although in a different 
solvent. [44] 1H and 13C NMR spectra of 6-deoxy-D-allose 7 in D2O, pH=6.1, showed four spin-systems 
[Table 3], confirmed as the pyranose and furanose forms by the HMBC correlations between H1 and 
C5 (pyranose) and C4 (furanose) (SI). The β-anomer of the pyranose forms was identified by the 
large trans-diaxial coupling between H1 and H2 and a strong ROESY correlation between H1 and H5 
[Figure 2] The analysis of furanose forms was more difficult. The β-anomer was tentatively assigned 
on the basis of a weak H1 to H4 ROESY correlation, not observed for the α-anomer.  
 
Since 6-deoxy-β-D-allofuranose has an identical ring conformation to 6-deoxy-α-L-talofuranose (they 
only differ by the configuration at C5) [Figure 2], the NMR parameters of the α- and β-furanose 
forms of 7 should be very similar to the β- and α-furanose forms 8 respectively. This provides 
additional support for the assignment of the furanose α- and β-anomers in 7 and 8. 
 
4 L-gluco-analogues and L-manno-analogues 
 
Table 4: NMR comparison of anomeric protons of L-gluco-analogues 
 L-gluco-series 
 
 
OHO
HO OH
CH3
OH
 
12 
OHO
OH
CH3
OH
N3
 
38 
OHO
OH
CH3
OH
H2N
 
39 
OHO
OH
CH3
OH
AcHN
 
41 
OHO
OH
CH3
OH
F
 
17 
H1α/J1,2 5.10a/3.8b 5.29/3.7 5.38/3.5 5.06/3.5 5.38/4.0 
C1α 93.2 91.6 89.5 91.0 89.7 
H1β/J1,2 4.55/7.9 4.67/8.1 4.91/8.4 4.59/8.5 4.87/7.9 
C1β 96.9 95.5 93.1 95.4 92.5 
a: ppm; b: Hz. 
 
 
 
 
 
 
Table 5: NMR comparison of anomeric protons of L-manno-analogues 
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L-manno-series 
 
OHO
OH
CH3
OH
 
13 
OHO
OH
CH3
OH
N3
 
42 
OHO
OH
CH3
OH
H2N
 
43 
OHO
OH
CH3
OH
AcHN
 
45 
OHO
OH
CH3
OH
F
 
16 
H1α/J1,2 5.31a/3.7b 5.20/1.1 5.32/1.2 4.85/1.1 5.30/1.8 
J1,2’ 1.0 nac na na na 
C1α 91.7 92.7 90.8 94.8 91.8 
H1β/J1,2 4.91/9.8 5.01/1.1 5.17/1.5 4.72/1.5 4.98/0 
J1,2’ 2.0 na na na na 
C1β 93.8 93.4 91.3 95.0 92.7 
a: ppm; b: Hz; c: not available. 
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Figure 3: Conformations of 2-substituted L-quinovose and L-rhamnose 
 
The ten L-gluco-series and L-manno-series targets synthesized from benzylidene protected L-
rhamnonolactone 9, have similar NMR spectra to those of glucose and mannose. [45]  
 
 
 
 
 
Table 5: NMR comparison of anomeric protons of L-manno-analogues and 错误! 未找到引用源。  
show the anomeric 1H, 13C shifts and their coupling constants, in D2O. The pyranose forms were the 
predominant (>95% NMR ratio) in all analogues as judged by the intensities of the 13C NMR peaks in 
the region associated with pyranose forms (δ = 93 – 97 ppm) compared to the intensities in the region 
associated with furanose forms (whose anomeric carbons are generally at lower field). In the L-gluco-
series (12, 38, 39, 41, 17) and L-olivose 13, the 1H NMR peaks of β-anomeric protons were showed 
larger coupling constants (J1,2 = 8 - 9 Hz) than their α counterparts (J1,2 = 3 - 4 Hz) because of the 
trans-diaxial configuration [Figure 3]. In contrast, in the L-manno-series, the magnitude of the 
coupling constants of anomeric protons were similar due to the trans-diequatorial or cis-equatorial-
axial configurations (J1,2 = 0 - 2 Hz) [Figure 3], while the 1H peaks of α-anomers were in lower field 
than their β counterparts, which was consistent with NMR data of L-rhamnose. [45c] 
 
CONCLUSION 
 
This paper describes the efficient production of 15 6-deoxy-sugars from L-rhamnose by a synergy of 
chemical synthesis and biotechnology as part of a project to find alternative non-metabolizable 
inducers to rhamnose for the L-rhamnose operon. Several inducers with different activities were 
identified: 1-deoxy-L-fructose 19 and 6-deoxy-L-altrose 18 were weak inducers; L-olivose 13 and 6-
deoxy-2-fluoro-L-rhamnose 16 were moderate inducers. Further studies explored their induction 
kinetics and confirmed L-olivose 13, 6-deoxy-2-fluoro-L-rhamnose 16 and 6-deoxy-L-altrose 18 were 
		 11	
poorly metabolized in E. coli. and gave sustained induction. [12] Such inducers with different strength 
could be used for different purposes e.g. production of toxic protein, production of certain protein in 
constant rate. Rhamnonolactones have rarely been used as chirons46 but are ideal intermediates for the 
chemical modification of rhamnose. Full NMR characterization of several 6-deoxyhexoses has been 
provided for the first time. 
 
EXPERIMENTAL SECTION 
 
General Experimental 
 
All commercial reagents were used as supplied. Solvents were used as supplied (Analytical or HPLC 
grade), without prior purification. Thin layer chromatography (TLC) was performed on aluminium 
sheets coated with 60 F254 silica. Plates were visualised using a 0.2% w/v cerium (IV) sulfate and 5% 
ammonium molybdate solution in 2 M sulfuric acid. Melting points were recorded on a Kofler hot 
block and are uncorrected. Optical rotations of the protected sugars were recorded on a Perkin-Elmer 
241 polarimeter with a path length of 1 dm; concentrations are quoted in g 100 mL-1. Optical rotations 
were recorded on a Jasco R1030 polarimeter, Na+ lamp, (Jasco, Tokyo, Japan) at 20 °C, polarimeter 
with a path length of 1 dm. Infrared spectra were recorded on a Perkin-Elmer 1750 IR Fourier 
Transform spectrophotometer using thin films on a diamond ATR surface (thin film). Only the 
characteristic peaks are quoted. Nuclear magnetic resonance (NMR) spectra were recorded on a 
Bruker AMX 500 (1H: 500 MHz and 13C: 125.7 MHz) or Bruker AVIII 400 HD nanobay and Bruker 
DQX 400 (1H: 400 MHz, 13C: 100.6 MHz and 19F: 375 MHz) or Bruker DPX 250 (1H: 250 MHz and 
13C: 62.5 MHz) or Varian Mercury 300 (1H: 300 MHz, 13C: 75 MHz) spectrometers in the deuterated 
solvent stated. 1H and 13C NMR spectra were assigned by utilizing 2D COSY, HSQC and HMBC 
spectra. All chemical shifts (δ) are quoted in ppm and coupling constants (J) in Hz. Residual signals 
from the solvents were used as an internal reference. For solutions in D2O acetonitrile was used as an 
internal reference. HRMS measurements were made using a microTOF mass analyzer using 
electrospray ionization (ESI) or an HP 5988A mass spectrometer using chemical ionization (CI). 
Commercial sample of 6-deoxy-D-glucose was kindly provided by Carbosynth Limit. 
 
A. Stereoisomers at C4 and C5 of rhamnose from 2,3-O-isopropylidene rhamnonolactone 2 
 
2,3-O-Isopropylidene-L-rhamnono-1,4-lactone 2 
Concentrated sulphuric acid (0.3 mL) was added to a suspension of anhydrous copper sulphate (25 g) 
in a solution of L-rhamnono-1,4-lactone (5.29 g, 32.65 mmol) in acetone (400 mL) and the mixture 
was stirred at rt overnight. TLC analysis (methanol/ethyl acetate, 1:9) showed the consumption of the 
starting material (Rf 0.4) and the formation of one product (Rf 0.7). The reaction mixture was 
neutralized with potassium carbonate (8 g) and filtered through Celite®, which was washed with 
acetone (2 x 25 mL). The liquids were removed in vacuo and the resulting crude solid was purified by 
flash column chromatography (ethyl acetate/ hexane, 1:1) to give the acetonide 2 (4.56 g, 69%) as a 
colourless oil. 
 [α]D20 = -47.8 (c = 2.7 in CHCl3) {lit. [15a] [α]D23 = -28 (c = 1.2 in Me2CO)}; 1H NMR (250 MHz, 
CDCl3): δ = 4.94 (dd, J3,2 5.5 Hz, J3,4 3.6 Hz, 1H; H3), 4.82 (br-d, J2,3 5.5 Hz, 1H; H2), 4.16 (dd, J4,5 = 
8.3 Hz, J4,3 = 3.6 Hz, 1H; H4), 4.09 (dq, J5,4 = 8.3 Hz, J5,6 = 6.3 Hz, 1H; H5), 2.33 (br-s, 1H; OH), 
1.46 (s, 3H; CH3), 1.39 (s, 3H; CH3), 1.37 (d, J6,5 = 6.3 Hz, 3H; H6); 13C NMR (62.5 MHz, CDCl3): δ 
= 173.9 (C=O), 114.5 (C(CH3)2), 82.0 (C4), 76.3 (C2), 76.2 (C3), 65.8 (C5), 26.8 (CH3), 26.0 (CH3), 
20.3 (C6); IR (thin film): νmax = 3465 (OH), 1784 (C=O); m/z (CI+ve): 203.2 ([M+H]+, 85%), 187.1 
([M-CH3]+, 100%); HRMS m/z (CI+ve): found 203.0929 [M+H]+; C9H15O5+ requires 203.0919;. 
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6–Deoxy-2,3-O-isopropylidene-L-lyxo-hex-5-ulosono-1,4-lactone 21 
Dess-Martin periodinane (3.00 g, 6.80 mmol) was added in three portions to a solution of the alcohol 
2 (1.10 g, 5.44 mmol) in dichloromethane (26 mL) at 0 °C. The reaction mixture was stirred at 0 °C 
for 2 h, after which TLC analysis (diethyl ether) revealed the absence of starting material (Rf 0.6) and 
the formation of one major product (Rf 0.8). The reaction mixture was filtered through Celite®, which 
was washed with dichloromethane (2 x 10 mL), and the liquids were concentrated in vacuo. The 
residue was then dissolved in dichloromethane (30 mL) and washed with sodium thiosulfate (sat. aq., 
15 mL) and brine (15 mL). The organic layer was dried (anhydr. Na2SO4) and concentrated in vacuo; 
the residue was purified by flash column chromatography (ethyl acetate/hexane, 1:1) affording the 
ketone 21 (0.85 g, 77%) as a white solid.  
m.p.: 142-144 ºC; {lit. [11b]  m.p.: 124-125 ºC} [α]D20 = +3.5 (c = 2.2 in CHCl3); 1H NMR (300 MHz, 
CDCl3): δ = 5.08 (dd, J3,4 = 4.9 Hz, J3,2 = 4.4 Hz, 1H; H3), 4.87 (d, J3,4 = 4.9 Hz, 1H; H4), 4.83 (d, J2,3 
= 4.4 Hz, 1H; H2), 2.28 (s, 3H; H6), 1.43 (s, 3H; CH3), 1.35 (s, 3H; CH3); 13C NMR (75 MHz, 
CDCl3): δ = 202.4 (C=O), 173.1 (C=O), 114.9 (C(CH3)2), 81.6 (C4), 77.5 (C2), 75.7 (C3), 27.8 (C6), 
26.7 (CH3), 25.8 (CH3); IR (thin film): νmax = 1789 (C=O), 1724 (C=O); m/z (CI+ve): 223.0 ([M+Na]+, 
100%); HRMS (ESI+ve) found 223.0571 [M+Na]+; C9H12NaO5+ requires 223.0577. 
 
6-Deoxy-2,3-O-isopropylidene-D-gulono-1,4-lactone 22 (from ketone 21) 
Sodium borohydride (0.015 g, 0.40 mmol) was added in two portions to a solution of the ketone 21 
(0.230 g, 1.15 mmol) in methanol (1.2 mL). The reaction mixture was stirred at rt for 15 min, when 
TLC analysis (diethyl ether) revealed the transformation of the starting material (Rf 0.8) into one 
major product (Rf 0.6). Ammonium chloride (sat. aq., 3 mL) was added and the mixture was extracted 
with ethyl acetate (5 x 5 mL). 1H-NMR analysis of the crude mixture showed an approximate 1.5:1 
ratio of the major products, the D-gulono- 22 and L-rhamnono-1,4-lactone 2 derivatives. Flash column 
chromatography of the mixture (ethyl acetate/hexane, 1:1) yielded lactone 22 (Rf 0.6) as a white solid 
(0.126 g, 54%). 
m.p.: 183-185 ºC; [α]D20 = -82.0 (c = 0.4 in CHCl3) {lit. [21] m.p.: 142-144 ºC; [α]D20 -64.1 (c = 1.2 in 
EtOH)}; 1H NMR (250 MHz, CD3OD): δ = 4.98 (d, J2,3 5.5 Hz, 1H; H2), 4.86 - 4.80 (m, 1H; H3), 
4.32 (dd, J4,5 8.8 Hz, J4,3 3.8 Hz, 1H; H4), 4.01-4.10 (m, 1H; H5), 1.44 (s, 3H; CH3), 1.41 (s, 3H; CH3), 
1.31 (d, J6,5 6.4 Hz, 3H; H6); 13C NMR (62.5 MHz, CD3OD): δ = 176.5 (C=O), 114.8 (C(CH3)2), 85.4 
(C4), 78.3 (C2), 78.1 (C3), 67.5 (C5), 27.1 (CH3), 26.0 (CH3), 18.4 (C6); IR (thin film): νmax = 3421 
(OH), 1774 (C=O); m/z (CI+ve): 203.2 ([M+H]+, 80%), 187.2 ([M-CH3], 100%); HRMS m/z (CI+ve): 
found 203.0918 [M+H]+; C9H15O5+ requires 203.0919. 
 
6-Deoxy-2,3-O-isopropylidene-D-gulose 3 
Diisobutylaluminium hydride (25 % wt. in toluene, 1.17 mL, 2.04 mmol) was added dropwise to a 
solution of 6-deoxy-2,3-O-isopropylidene-D-gulono-1,4-lactone 22 (0.165 g, 0.82 mmol) in 
anhydrous DCM (2.4 mL) at -78 °C. The reaction mixture was stirred at -78 °C for 30 min, until TLC 
(hexane/ethyl acetate, 1:1) indicated the formation of one major product (Rf 0.2). The reaction 
mixture was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), potassium 
dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were added and the 
mixture was stirred for 10 min. The mixture was dried (anhydr. Na2SO4), filtered through Celite®, the 
solids were washed with ethyl acetate (3 x 10 mL) and the liquids were concentrated in vacuo. Flash 
column chromatography (hexane/ethyl acetate, 1:1) of the residue provided 6-deoxy-2,3-O-
isopropylidene-D-gulose, 3 as a white solid (0.12 g, 75%). 
 [α]D20 = -37.8 (c = 4.8 in CHCl3); Major component: 1H NMR (250 MHz, CD3OD): δ = 5.30 (s, 1H; 
H1), 4.78 (d, J2,3 = 5.9 Hz, 1H; H2), 4.59 (a-d, J3,2 = 5.9 Hz, 1H; H3), 3.98 (m, 1H; H5), 3.92 (dd, J4,5 
		 13	
= 8.3 Hz, J4,3 = 3.5 Hz, 1H; H4), 1.46 (s, 3H; CH3), 1.35 (s, 3H; CH3), 1.30 (d, J6,5 = 6.3 Hz, 3H; H6); 
13C NMR (62.5 MHz, CD3OD): δ = 113.4 (C(CH3)2), 102.0 (C1), 87.5 (C2), 85.7 (C4), 81.3 (C3), 
67.7 (C5), 26.4 (CH3), 24.9 (CH3), 19.3 (C6); IR (thin film): νmax = 3420 (OH); m/z (CI+ve): 205.2 
([M+H]+, 30%), 187.2 ([M-OH]+, 100%); HRMS m/z (CI+ve): found 205.1071 [M+H]+; C9H17O5+ 
requires 205.1076. 
 
6-Deoxy-D-gulose 6 
DOWEX® 50WX8-100 (H+ form) (0.07 g) was added into a solution of the lactols 3 (0.074 g, 0.36 
mmol) in water (2 mL); after stirring at rt for 24 h, TLC analysis (hexane/ethyl acetate, 1:1.5) 
indicated the absence of the starting material (Rf 0.5) and the formation of one polar major product (Rf 
0.0). The resin was filtered and washed with water (2 x 2 mL), the liquids were concentrated in vacuo 
and the residue was purified by column chromatography (methanol/dichloromethane, 1:6), to obtain a 
10:1 mixture of β- and α- anomers of 6-deoxy-D-gulopyranose, 6 respectively (0.055 g, 93%), as a 
syrup. 
 [α]D20 = -20.3 (c = 0.6 in H2O) {lit. [23] [α]D20 = -39 (c = 2.0 in H2O)}; 1H NMR (400 MHz, CD3OD): δ 
= 5.11 (d, J1,2 = 3.0 Hz, 1H; H1α), 4.85 (d, J1,2 = 8.3 Hz, 1H; H1β), 4.37 (dq, J5,4 = 1.0 Hz, J5,6 = 6.6 
Hz, 1H; H5α), 4.10 (dq, J5,4 = 0.6 Hz, J5,6 = 6.5 Hz, 1H; H5β), 4.07 (t, J3,4 = J3,2 = 3.2 Hz, 1H; H3β), 
4.01 (dd, J3,2 = 3.3 Hz, J3,4 = 4.0 Hz, 1H; H3α), 3.88 (dd, J2,3 = 3.0 Hz, J2,1 = 3.3 Hz, 1H; H2α), 3.75 
(dd, J4,5 = 1.0 Hz, J4,3 = 4.0 Hz, 1H; H4α), 3.62 (dd, J4,5 = 0.6 Hz, J4,3 = 3.2 Hz, 1H; H4β), 3.57 (dd, 
J2,3 = 3.2 Hz, J2,1 = 8.3 Hz, 1H; H2β), 1.22 (d, J6,5 = 6.5 Hz, 3H; H6β), 1.21 (d, J6,5 = 6.6 Hz, 3H; 
H6α); 13C NMR (100 MHz, D2O): δ = 92.8 (C1β), 91.9 (C1α), 71.0 (C4β), 70.6 (C4α), 70.4 (C3β), 
70.0 (C3α), 68.4 (C5β), 68.0 (C2β), 63.8 (C2α), 61.5 (C5α), 14.3 (C6β), 13.8 (C6α); IR (thin film): 
νmax = 3367 (OH); m/z (CI+ve): 165.1 ([M+H]+, 3%), 147.1 ([M-OH]+, 100%); HRMS m/z (CI+ve): 
found 165.0768 [M+H]+; C6H13O5+ requires 165.0763. 
 
6-Deoxy-2,3-O-isopropylidene-D-allono-1,4-lactone 24 
Methanesulfonyl chloride (2.97 mL, 38.33 mmol) and N,N-dimethylaminopyridine (0.37 g, 3.07 
mmol) were added under argon to a solution of the protected lactone 2 (6.20 g, 30.66 mmol) in 
anhydrous pyridine (30 mL) at 0 °C. The reaction mixture was stirred at 0 ºC for 3 h, after which TLC 
analysis (hexane/ethyl acetate, 1:1.5, 2 runs) indicated the consumption of the starting material (Rf 
0.3) and the formation of one major product (Rf 0.4). The mixture was concentrated in vacuo and co-
evaporated with toluene (3 x 20 mL) and the residue was dissolved in dichloromethane (60 mL) and 
washed with water (40 mL) and with brine (40 mL). The organic layer was dried (anhydr. Na2SO4) 
and concentrated in vacuo, and the residue was purified by flash column chromatography (ethyl 
acetate/hexane, 1:1.3) affording the mesylate 23 (7.13 g, 83 %) as a white solid.  
 [α]D20 = -39.5 (c = 1.9 in CHCl3); 1H NMR (300 MHz, CDCl3): δ = 4.98 (dq, J5,6 = 6.6 Hz, J5,4 = 7.7 
Hz, 1H; H5), 4.85-4.90 (m, 2H; H2, H3), 4.42 (dd, J4,3 = 2.7 Hz, J4,5 = 7.7 Hz, 1H; H4), 3.06 (s, 3H; 
CH3-SO3), 1.60 (d, J6,5 = 6.6 Hz, 1H; H6), 1.48 (s, 3H; CH3), 1.39 (s, 3H; CH3); 13C NMR (75 MHz, 
CDCl3): δ = 172.9 (C=O), 114.7 (C(CH3)2), 79.1 (C4), 76.2 (C2), 75.4 (C3, C5), 38.7 (CH3-SO3), 26.9 
(CH3), 26.0 (CH3), 18.9 (C6); IR (thin film): νmax = 1774 (C=O); m/z (CI+ve): 281.4 ([M+H]+, 53%), 
157.3 ([M-C3H7O3S]+, 100%); HRMS m/z (CI+ve): found 303.0509 [M+Na]+; C10H16O7S+ requires 
303.0508. 
 
A solution of mesylate 23 in 1,4-dioxane (113 mL) and aqueous potassium hydroxide (0.85 M, 90 mL, 
76.3 mmol) was stirred at rt overnight. The reaction mixture was acidified to pH 1 with hydrochloric 
acid (2 M, aq.) and extracted with ethyl acetate (6 x 100 mL). TLC analysis (hexane/ethyl acetate, 
1:1) indicated the transformation of the starting material (Rf 0.3) into a mixture of lactone 24 (minor 
component, Rf 0.3) and base line material (major component, Rf 0.0). The pooled organic extracts 
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were stirred in presence of anhydrous Na2SO4 at rt overnight in order to complete the lactonization to 
24. The solids were filtered off and the reaction mixture concentrated in vacuo. Flash column 
chromatography (diethyl ether/hexane, 2.5:1) of the residue afforded the allono-lactone 24 (4.07 g, 
79 %; 66% over two steps) as white solid.  
m.p.: 165-167 ºC; [α]D20 = -62.1 (c = 3.2 in CHCl3); 1H NMR (300 MHz, CDCl3): δ = 4.78 (d, J2,3 = 
2.2 Hz, 1H; H2), 4.76 (d, J3,2 = 2.2 Hz, 1H; H3), 4.38 (d, J4,5 = 2.2 Hz, 1H; H4), 4.10 (dq, J5,6 = 6.7 Hz, 
J5,4 = 2.2 Hz, 1H; H5), 3.36 (br-s, 1H; OH), 1.42 (s, 3H; CH3), 1.34 (s, 3H; CH3), 1.27 (d, J6,5 = 6.3 
Hz, 3H; H6); 13C NMR (75 MHz, CDCl3): δ = 175.2 (C=O), 113.1 (C(CH3)2), 86.6 (C4), 75.8 (C2), 
75.7 (C3), 66.6 (C5), 26.7 (CH3), 25.4 (CH3), 18.4 (C6); IR (thin film): νmax = 3432 (OH), 1788 
(C=O); m/z (CI+ve): 203.2 ([M+H]+, 68%), 187.2 ([M-CH3]+, 100%); HRMS m/z (CI+ve): found 
203.0918 [M+H]+; C9H15O5+ requires 203.0913. 
 
6-Deoxy-2,3-O-isopropylidene-L-talono-1,4-lactone 26 
Triflic anhydride (0.6 mL, 3.56 mmol) was added dropwise to a solution of the gulono-lactone (0.6 g, 
2.97 mmol) and anhydrous pyridine (0.72 mL, 8.91 mmol) in anhydrous dichloromethane (20 mL) at 
-30 °C. The reaction mixture was stirred between -30 and -10 °C for 1 h, after which TLC 
(hexane/ethyl acetate, 1:1) showed the consumption of the starting material (Rf 0.3) and the formation 
of one major product (Rf 0.6). The reaction mixture was diluted with DCM (30 mL) and washed with 
hydrochloric acid (1 M, aq. 10 mL). The organic layer was dried (anhydrous Na2SO4), filtered and the 
solvent removed in vacuo affording triflate 25 (1.10 g) as white solid.  
A solution of the crude triflate 25 and sodium trifluoroacetate (1.21 g, 8.91 mmol) in pentanone (10 
mL) was stirred at rt for 2 h, when TLC analysis (hexane/ethyl acetate, 1:1) showed the 
transformation of the starting material (Rf 0.6) into a mixture of its trifluoroacetate derivative (Rf 0.5) 
and 26 (Rf 0.3). Methanol (10 mL) was added and the reaction mixture was stirred at rt for 6 h, until 
TLC analysis (hexane/ethyl acetate, 1:1) showed the total transformation of the major component into 
the reaction product 26 (Rf 0.3). The reaction mixture was concentrated in vacuo, and the residue was 
dissolved in ethyl acetate (10 mL) and washed with water (3 x 5 mL). The organic layer was dried 
(anhydr. Na2SO4), filtered and concentrated in vacuo. Flash column chromatography (ethyl 
acetate/hexane, 1:1) of the residue afforded the talono-lactone 26 (0.42 g, 70%) as a white solid. 
m.p.: 58-61ºC; [α]D20 = -26.6 (c = 3.1 in CHCl3); 1H NMR (250 MHz, CDCl3): δ = 4.80 (d, J2,3 = 5.6 
Hz, 1H; H2), 4.73 (d, J3,2 = 5.6 Hz, 1H; H3), 4.41 (d, J4,5 = 1.5 Hz, 1H; H4), 4.01 (dq, J5,6 = 6.5 Hz, 
J5,4 = 1.5 Hz, 1H; H5), 2.45 (br-s, 1H; OH), 1.44 (s, 3H; CH3), 1.36 (s, 3H; CH3), 1.35 (d, J6,5 = 6.5 
Hz, 3H; H6); 13C NMR (62.5 MHz, CDCl3): δ = 175.5 (C=O), 113.1 (C(CH3)2), 85.8 (C4), 78.9 (C2), 
75.2 (C3), 67.5 (C5), 26.8 (CH3), 25.5 (CH3), 19.4 (C6); IR (thin film): νmax = 3436 (OH), 1773 
(C=O); m/z (CI+ve): 203.2 ([M+H]+, 70%), 187.2 ([M-CH3]+, 100%); HRMS m/z (CI+ve): found 
203.0934 [M+H]+; C9H15O5+ requires 203.0929. 
 
6-Deoxy-2,3-O-isopropylidene-α-D-allose 4 
Diisobutylaluminum hydride (25 % wt in toluene, 0.64 mL, 1.12 mmol) was added dropwise to a 
solution of the allono-lactone 24 (0.09 g, 0.45 mmol) in anhydrous dichloromethane (0.70 mL) at -
78 °C. The reaction mixture was stirred at -78 °C for 30 min until TLC (hexane/ethyl acetate 1:1) 
indicated the comsumption of the starting material (Rf 0.4) and formation of one major product (Rf 
0.3). The reaction was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), 
potassium dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were 
added and the mixture was stirred for 10 min. The mixture was dried (anhydrous Na2SO4), filtered 
through Celite®. The solids were washed with ethyl acetate (3 x 10 mL) and the liquids were 
concentrated in vacuo. Flash column chromatography (ethyl acetate/hexane, 1:1) of the crude afforded 
the lactols 4 (0.55 g, 91%) as a pale yellow oil. 
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 [α]D20 = -41.0 (c = 0.7 in CHCl3); Major component: 1H NMR (300 MHz, CDCl3): δ = 5.40 (s, 1H; 
H1), 4.87 (d, J2,3 = 5.9 Hz, 1H; H2), 4.56 (d, J3,2 = 5.9 Hz, 1H; H3), 4.15 (br-s, 1H; OH), 3.91-4.02 (m, 
2H; H4, H5), 1.48 (s, 3H; CH3), 1.32 (s, 3H; CH3), 1.25 (d, J6,5 = 6.6 Hz, 3H; H6); 13C NMR (75 MHz, 
CDCl3): δ = 111.9 (C(CH3)2), 102.1 (C1), 91.5 (C2), 86.5 (C4), 79.3 (C3), 67.9 (C5), 26.1 (CH3), 24.5 
(CH3), 18.3 (C6); IR (thin film): νmax = 3371 (OH); m/z (CI+ve): 205.2 ([M+H]+, 68%), 187.2 ([M-
OH]+, 100%); HRMS m/z (CI+ve): found 205.1078 [M+H]+; C9H17O5+ requires 205.1076. 
 
6-Deoxy-D-allose 7 
DOWEX® 50WX8-100 (H+ form) (0.3 g) was added to a solution of crude 6-deoxy-2,3-O-
isopropylidene-D-allofuranose 4 (0.3 g, 1.47 mmol) in water (8.5 mL). After stirring at rt for 24 h, 
TLC analysis (ethyl acetate) indicated the absence of the starting material (Rf 0.8) and the formation 
of one polar major product (Rf 0.0). The resin was filtered and washed with water (2 x 8 mL), the 
liquids were concentrated in vacuo and the residue was purified by column chromatography 
(methanol/dichloromethane, 1:6) to obtain 6-deoxy-D-allose 7 (0.23 g, 95%), as a white solid.  
m.p.: 144-146 ºC (methanol/dichloromethane), {lit. [26] 151-152 ºC}, [α]D20 (initial) = -7.0 (c = 0.33 in 
H2O), [α]D20 (eqm. after 30 min) = +2.0 (c = 0.33 in H2O); 1H NMR (500 MHz, D2O): Pyranose: δ = 
5.08 (d, J1,2 = 3.4 Hz, 1H; H1α), 4.85 (d, J1,2 = 8.3 Hz, 1H; H1β), 4.12 (dd, J3,4 = 2.8 Hz, J3,2 = 3.0 Hz, 
1H; H3β), 4.12 (m (weak), 1H; H3α), 4.04 (dq, J5,6 = 6.4 Hz, J5,4 = 9.4 Hz, 1H; H5α), 3.82 (dq, J5,6 = 
6.3 Hz, J5,4 = 9.8 Hz, 1H; H5β), 3.70 (t, J2,1 = J2,3 = 3.4 Hz, 1H; H2α), 3.40 (dd, J2,3 = 3.0 Hz, J2,1 = 
8.3 Hz, 1H; H2β), 3.36 (dd, J4,3 = 2.8 Hz, J4,5 = 9.8 Hz, 1H; H4β), 3.36 (m (weak), 1H; H4α), 1.26 (d, 
J6,5 = 6.4 Hz, 3H; H6α), 1.24 (d, J6,5 = 6.3 Hz, 3H; H6β); Furanose: δ = 5.35 (d, J1,2 = 4.2 Hz, 1H; 
H1α), 5.22 (d, J1,2 = 2.3 Hz, 1H; H1β), 4.30 (t, J3,2 = J3,4 = 5.2 Hz, 1H; H3β), 4.16 (dd, J3,4 = 3.9 Hz, 
J3,2 = 5.9 Hz, 1H; H3α), 4.04 (m (weak), 1H; H2α), 4.00 (dd, J4,5 = 3.8 Hz, J4,3 = 3.9 Hz, 1H; H4α), 
3.94 (m (weak), 1H; H2β), 3.93 (m (weak), 2H; H5α and H5β), 3.82 (m (weak), 1H; H4β), 1.22 (d, 
J6,5 = 6.7 Hz, 3H; H6β), 1.20 (d, J6,5 = 6.7 Hz, 3H; H6α); 13C NMR (125 MHz, D2O): Pyranose: δ = 
94.0 (C1β), 93.4 (C1α), 72.9 (C4β), 17.2 (C6α), 72.3 (C4α), 72.1 (C2β, C3α), 71.7 (C3β), 68.0 (C2α), 
70.1 (C5β), 63.5 (C5α), 17.6 (C6β),  Furanose: δ = 101.1 (C1β), 96.6 (C1α), 87.8 (C4α), 86.3 (C4β), 
76.1 (C2β), 71.8 (C2α), 70.7 (C3β), 69.4 (C3α), 68.1 (C5β), 67.6 (C5α), 17.9 (C6α, C6β),; IR (thin 
film): νmax = 3377 (OH); m/z (CI+ve): 165.1 ([M+H]+, 5%), 147.2 ([M-OH], 100%); HRMS m/z 
(CI+ve): found 165.0764 [M+H]+; C6H13O5+ requires 165.0763.  
 
6-Deoxy-2,3-O-isopropylidene-L-talose 5 
Diisobutylaluminum hydride (25 % wt. in toluene, 3 mL, 5.23 mmol) was added dropwise to a 
solution of the talono-lactone 26 (0.5 g, 2.47 mmol) in anhydrous dichloromethane (7 mL) at -78 °C. 
The reaction mixture was stirred at -78 °C for 30 min, until TLC (hexane/ethyl acetate, 1:1) indicated 
the consumption of the starting material (Rf 0.3) and formation of one major product (Rf 0.4). The 
reaction was quenched with methanol and allowed to warm to rt. Ethyl acetate (2 mL), potassium 
dihydrogen orthophosphate (2 g) and sodium hydrogen carbonate (sat. aq., 2 mL) were added and the 
mixture was stirred for 10 min. The mixture was dried (anhydr. Na2SO4) and filtered through Celite®. 
The solids were washed with ethyl acetate (3 x 10 mL) and the liquids concentrated in vacuo. Flash 
column chromatography (hexane/ethyl acetate, 1:1) of the residue provided the talo-lactols 5 (0.40 g, 
1.97 mmol, 80% yield) as a colourless oil. 
 [α]D20 = -3.7 (c = 0.8 in CHCl3); Major component: 1H NMR (250 MHz, CDCl): δ = 5.24 (s, 1H; H1), 
4.89 (br-s, 1H; OH), 4.61 (d, J2,3 = 5.9 Hz, 1H; H2), 4.40 (d, J3,2 = 5.9 Hz, 1H; H3), 4.00 (d, J4,5 = 2.0 
Hz, 1H; H4), 3.63-3.77 (m, 1H; H5), 1.33 (s, 3H; CH3), 1.18 (s, 3H; CH3), 1.09 (d, J6,5 = 6.4 Hz, 3H; 
H6); 13C NMR (62.5 MHz, CDCl3): δ = 111.9 (C(CH3)2), 102.5 (C1), 90.6 (C2), 86.2 (C4), 82.3 (C3), 
67.7 (C5), 26.2 (CH3), 24.5 (CH3), 19.4 (C6); IR (thin film): νmax = 3370 (OH); m/z (CI+ve): 205.2 
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([M+H]+, 2%), 187.2 ([M-OH]+, 100%); HRMS m/z (CI+ve): found 205.1070 [M+H]+; C9H17O5+ 
requires 205.1075. 
 
6-Deoxy-L-talose 8 
DOWEX® 50WX8-100 (H+ form) (0.3 g) was added into a solution of the lactols 5 (0.3 g, 1.47 mmol) 
in water (8.5 mL). After stirring at rt for 24 h, TLC analysis (ethyl acetate) indicated the absence of 
the starting material (Rf 0.8) and the formation of one polar major product (Rf 0.0). The resin was 
filtered off and washed with water (2 x 8 mL), the filtrate was concentrated in vacuo and the residue 
was purified by column chromatography (methanol/dichloromethane 1:6) to obtain 6-deoxy-D-talose 
8 as a white solid (0.216 g, 90%). 
m.p.: 126-128 ºC (methanol/dichloromethane); [α]D20 (initial) = -49 (c = 0.14 in H2O), [α]D20 (eqm. 
after 30 min) = -21; {lit. [27] m.p. 119-121 ºC, [α]D20 = -20.5 (c = 2.28 in H2O)}; 1H NMR (500 MHz, 
D2O): Pyranose: δ = 5.21 (d, J1,2 = 1.3 Hz, 1H; H1α), 4.77 (d, J1,2 = 1.1 Hz, 1H; H1β), 4.17 (dq, J5,4 = 
1.0 Hz, J5,6 = 6.7 Hz, 1H; H5α), 3.91 (t, J3,2 = J3,4 = 3.2 Hz, 1H; H3α), 3.85 (dd, J2,1 = 1.1 Hz, J2,3 = 
3.3 Hz, 1H; H2β), 3.80 (dd, J2,1 = 1.3 Hz, J2,3 = 3.2 Hz, 1H; H2α), 3.75 (t, J3,2 = J3,4 = 3.3 Hz, 1H; 
H3β), 3.74 (dd, J4,5 = 1.0 Hz, J4,3 = 3.2 Hz, 1H; H4α), 3.69 (dq, J5,4 = 1.0 Hz, J5,6 = 6.5 Hz, 1H; H5β), 
3.66 (dd, J4,5 = 1.0 Hz, J4,3 = 3.3 Hz, 1H; H4β), 1.27 (d, J6,5 = 6.5 Hz, 3H; H6β), 1.24 (d, J6,5 = 6.7 Hz, 
3H; H6α), Furanose: δ = 5.35 (d, J = 1.3 Hz, J = 2.6 Hz, 1H; H1β), 5.23 (d, J1,2 = 1.6 Hz, 1H; H1α), 
4.20 (dd, J3,2 = 4.9 Hz, J3,4 = 6.4 Hz, 1H; H3α), 4.08 (m (weak), 2H; H2β and H3β), 3.97 (dd, J2,1 = 
1.6 Hz, J2,3 = 4.9 Hz, 1H; H2α), 3.90 (m (weak), 1H; H4β), 3.84 (m (weak), 1H; H5β), 3.83 (dq, J5,6 = 
6.3 Hz, J5,4 = 6.4 Hz, 1H; H5α), 3.71 (t, J4,5 = J4,3 = 6.4 Hz, 1H; H4α), 1.23 (d, J6,5 = 6.3 Hz, 3H; H6α), 
1.22 (d, J6,5 = 6.4 Hz, 3H; H6β); 13C NMR (125 MHz, D2O): Pyranose: δ = 95.3 (C1α), 94.6 (C1β), 
72.8 (C4α), 71.9 (C5β), 71.8 (C2β), 71.7 (C4β), 71.0 (C2α), 69.3 (C3β), 67.6 (C5α), 66.0 (C3α), 16.4 
(C6α), 16.2 (C6β), Furanose: δ = 101.3 (C1α), 96.8 (C1β), 87.1 (C4β), 86.4 (C4α), 76.0 (C2α), 71.7 
(C3α), 71.6 (C2β), 71.3 (C3β), 69.5 (C5α), 67.9 (C5β), 19.0 (C6β), 18.7 (C6α); IR (thin film): νmax = 
3386 (OH); m/z (CI+ve): 165.1 ([M+H]+, 1%), 147.1 ([M-OH]+, 100%); HRMS m/z (CI+ve): found 
165.0765 [M+H]+; C6H13O5+ requires 165.0760. 
 
6-Deoxy-2,3-O-isopropylidene-D-gulono-1,4-lactone 22 (from talono-lactone 26) 
Methanesulfonyl chloride (0.1 mL, 1.28 mmol) and N,N-dimethylaminopyridine (0.013 g, 0.10 mmol) 
were added under argon to a solution of the talono-lactone 26 (0.21 g, 1.03 mmol) in anhydrous 
pyridine (1.4 mL) at 0 °C. The reaction mixture was stirred at 0 ºC for 3 h, when TLC (hexane/ethyl 
acetate, 1:1) showed the consumption of starting material (Rf 0.3) and the formation of one reaction 
product (Rf 0.4). The solvent was evaporated in vacuo and the residue co-evaporated with toluene (3 x 
2 mL). The residue was dissolved in DCM (10 mL) and washed with water (5 mL) and brine (5 mL). 
The organic layer was dried (anhydr. Na2SO4), filtered and concentrated in vacuo, affording mesylate 
27 (0.25 g, 86 %) as a white solid.  
m.p.: 75 ºC (ethyl acetate/hexane); [α]D20 = -36.7 (c = 0.4 in MeOH); 1H NMR (300 MHz, CDCl3): δ = 
5.04 (dq, J5,6 = 6.6 Hz, J5,4 = 1.7 Hz, 1H; H5), 4.76-4.81 (m, 2H; H3, H4), 4.55 (d, J = 7.7 Hz, 1H; 
H2), 3.06 (s, 3H; CH3-SO3), 1.54 (d, J6,5 = 6.6 Hz, 1H; H6), 1.45 (s, 3H; CH3), 1.37 (s, 3H; CH3); 13C 
NMR (75 MHz, CDCl3): δ = 173.6 (C=O), 113.9 (C(CH3)2), 83.6 (C4), 78.2 (C2), 76.8 (C5), 74.7 
(C3), 39.6 (CH3-SO3), 26.8 (CH3), 25.6 (CH3), 17.4 (C6); IR (thin film): νmax = 1781 (C=O);  m/z 
(CI+ve): 281.4 ([M+H]+, 35%), 157.3 ([M-C3H7O3S]+, 100%); HRMS m/z (CI+ve): found 281.0706 
[M+H]+; C10H17O7S+ requires 281.0703. 
 
Aqueous potassium hydroxide (0.60 M, 3.9 mL, 2.34 mmol) was added to a solution of crude 
mesylate 27 (0.22 g, 0.78 mmol) in 1,4-dioxane (5 mL) and the mixture was stirred at rt overnight. 
The reaction mixture was acidified to pH 1 with hydrochloric acid (2 M, aq.) and extracted with ethyl 
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acetate (6 x 10 mL). TLC analysis (hexane/ethyl acetate, 1:1) indicated the transformation of the 
starting material (Rf 0.4) into a mixture of lactone 22 (Rf 0.2) and its carboxylic acid precursor (Rf 
0.0). The pooled organic extracts were stirred in presence of Na2SO4 (anhydr.) at rt overnight, filtered 
and concentrated in vacuo. Flash column chromatography (ethyl acetate/hexane, 1:1) of the solid 
residue afforded the gulono-lactone 22 (0.12 g, 76%) as a white solid. This sample was identical to 
that prepared above from ketone 21 and was converted to 6-deoxy-D-gulose 6 as described above for 
biological evaluation. 
 
B. 2-Substituted rhamnose analogues from 3,5-O-benzylidene rhamnonolactone 9 
 
3,5-O-Benzylidene-2-O-trifluoromethanesulfonyl-L-rhamnono-1,4-lactone 10  
Trifluoromethanesulfonyl anhydride (2.70 mL, 16.0 mmol) was added dropwise to a solution of the 
benzylidene lactone 9 (2.0 g, 8.0 mmol) and anhydrous pyridine (1.93 mL, 24.0 mmol) in anhydrous 
THF (30 mL) at -20 °C. After 2 h, TLC (cyclohexane/ethyl acetate, 1:1) indicated the consumption of 
the starting material (Rf 0.54) and the formation of one major product (Rf 0.61). The reaction mixture 
was diluted with dichloromethane (10 mL) and washed with HCl (2 M, aq., 3 x 40 mL). The organic 
layer was dried (MgSO4) and the solvent was removed in vacuo to give the residue which was 
purified by flash chromatography (cyclohexane/ethyl acetate, 5:1→3:1) to obtain pure triflate 10 (2.9 
g, 95%) as a white solid.  
m.p.: 115-117 °C; [α]D20 = -78 (c = 0.69 in CHCl3) {lit. [16] m.p.: 139-140 °C; [α]D20 = -63.9 (c = 0.69 
in CH3CN)}; 1H NMR (400 MHz, CD3CN): δ = 7.46–7.42 (m, 5H; -Ar), 5.97 (s, 1H; H7), 5.85 (d, J2,3 
= 3.9 Hz, 1H; H2), 5.23 (dd, J3,4 = 1.7 Hz, J3,2 = 3.9 Hz, 1H; H3), 4.60 (dq, J5,4 = 0.8 Hz, J5,6 = 7.3 Hz, 
1H; H5), 4.38 (br-s, 1H; H4), 1.55 (d, J6,5 = 7.3 Hz, 3H; H6); 13C NMR (100 MHz, CD3CN): δ = 
168.6 (C=O), 126.7, 128.9, 129.8, 137.9 (-Ar), 92.1 (C7), 81.1 (C2), 73.8 (C4), 71.0 (C3), 69.9 (C5), 
14.4 (C6); IR (thin film): vmax = 1780 (C=O); m/z (ESI+ve): 405 ([M+Na]+, 100%); HRMS (ESI+ve): 
found 405.0226 [M+Na]+; C14H13F3NaO7S+ requires 405.0226. 
 
3,5-O-Benzylidene-6-deoxy-L-glucono-1,4-lactone 28 
Cesium trifluoroacetate (4.45 g, 18.2 mmol) was added to a solution of triflate 10 (2.9 g, 7.6 mmol) in 
butanone (30 mL). The reaction mixture was then stirred at 60 °C for 4 h until TLC 
(cyclohexane/ethyl acetate, 1:1) indicated the disappearance of starting material (Rf 0.61) and the 
formation of one major product (Rf 0.57). Solvent was removed in vacuo to give a residue that was 
purified by flash chromatography (cyclohexane/ethyl acetate, 5:1→3:1) to obtain the glucono-lactone 
28 (1.8 g, 90%) as a white solid.  
m.p.: 146-148 °C; [α]D20 = -80 (c = 0.90 in MeCN) {lit. [16] m.p.: 145-148 °C; [α]D20 = -84.1 (c = 1.15 
in CH3CN)}; 1H NMR (400 MHz, CD3CN): δ = 7.39–7.46 (m, 5H; -Ar), 5.92(s, 1H; H7), 4.66 (d, J3,4 
= 2.0 Hz, 1H; H3), 4.57 (q, J5,6 = 7.2 Hz, 1H; H5), 4.47 (br-s, 1H; H4), 4.14 (br-s, 1H; H2), 1.54 (d, 
J6,5 = 7.2 Hz, 3H; H6); 13C NMR (100 MHz, CD3CN): δ = 175.6 (C=O), 127.1, 129.2, 129.6, 139.1 (-
Ar), 92.8 (C7), 77.5 (C4), 75.5 (C3), 73.8 (C2), 73.8 (C2), 15.3 (C6); IR (thin film): vmax = 1785 
(C=O); m/z (ESI+ve): 405 ([M+Na]+, 100%); HRMS (ESI+ve): found 273.0726 [M+Na]+; 
C13H14NaO5+ requires 273.0733. 
 
3,5-O-Benzylidene-2-O-tert-butyldimethylsilyl-6-deoxy-L-glucono-1,4-lactone 29 
tert-Butyldimethylsilyl chloride (111 mg, 0.74 mmol) and imidazole (78 mg, 1.14 mmol) were added 
to a solution of 28 (143 mg, 0.57 mmol) in anhydrous DMF (3 mL). The reaction mixture was stirred 
at rt for 15 h until TLC (cyclohexane/ethyl acetate, 1:1) showed the formation of one major product 
(Rf 0.8). Then the mixture was diluted with ethyl acetate (10 mL) and washed with half saturated 
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brine (10 mL). The organic phase was dried (MgSO4), filtered and solvent removed in vacuo to give a 
residue that was purified by flash chromatography (cyclohexane/ethyl acetate, 7:1→5:1) to yield the 
silyl ether 29 (148 mg, 71%) as a white solid. 
m.p.: 58-60 °C; [α]D20 = -70.9 (c = 1.17 in CHCl3); 1H NMR (400 MHz, CDCl3): δ = 7.37–7.47 (m, 
5H; -Ar), 5.8 (s, 1H; H7), 4.59 (dq, J5,4 = 0.8 Hz, J5,6 = 7.1 Hz, 1H; H5), 4.10 (d, J3,4 = 2.3 Hz, 1H; 
H3), 4.39 (dd, J4,5 = 1.8 Hz, J4,3 = 2.3 Hz, 1H; H4), 4.23 (s, 1H; H2), 1.56 (d, J6,5 = 7.1 Hz, 3H; H6), 
0.92 (s, 9H; 3 x CH3), 0.20 (s, 3H; CH3), 0.18 (s, 3H; CH3); 13C NMR (100 MHz, CDCl3): δ = 173.8 
(C=O), 126.3, 128.4, 129.4, 137.3 (-Ar), 92.7 (C7), 77.2 (C4), 75.4 (C3), 73.9 (C2), 68.8 (C5), 25.5 
(CH3), 15.5 (C6), -4.9 (CH3), -5.2 (CH3); IR (thin film): vmax = 1793 (C=O); m/z (ESI+ve): 387 
([M+Na]+, 100%); HRMS (ESI+ve): found 387.1597 [M+Na]+; C19H28NaO5Si+ requires 387.1598. 
 
3,5-O-Benzylidene-2-O-tert-butyldimethylsilyl-6-deoxy-L-glucose 30 
Diisobutylaluminium hydride (25% w/v in toluene, 0.30 mL, 0.53 mmol) was added dropwise to a 
solution of 29 (148 mg, 0.41 mmol) in anhydrous dichloromethane (3 mL) at -78 °C. The reaction 
mixture was stirred at -78°C for 1 h until mass spectrometry showed the formation of desired product 
peak and disappearance of starting material peak (m/z 364). Then the mixture was diluted with ethyl 
acetate (10 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring for 8 h, 
the mixture was diluted with water (10 mL) and extracted with ethyl acetate (3 x 10 mL). Organic 
phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a residue that was 
further purified via flash chromatography (cyclohexane/ethyl acetate, 7:1→5:1) to yield the lactols 30 
as a syrup (α:β ratio 5:4) (130 mg, 88%). 
 [α]D20 = -10 (c = 0.27 in CHCl3); 1H NMR (400 MHz, CD3CN): δ = 7.24-7.14 (m, 10H; -Arα, -Arβ), 
5.54 (s, 1H; H7α), 5.54 (s, 1H; H7β), 5.24 (dd, J1,2 = 3.6 Hz, J1,OH = 11.3 Hz, 1H; H1β), 4.78 (d, J1,OH = 
10.7 Hz, 1H; H1α), 4.15-4.18 (m, 3H; H3α, H3β, H5α), 4.07 (a-q, J5,6 = 7.2 Hz, 1H; H5β), 3.90 (d, J2,1 
= 3.5 Hz, 1H; H2β), 3.88 (br-s, 1H; H2α), 3.80 (d, JOH,1 = 11.1 Hz, 1H; OHβ), 3.64 (br-s, 2H; H4α, 
H4β), 3.59 (d, JOH,1 = 10.7 Hz, 1H; OHα), 1.23 (d, J6,5 = 7.2 Hz, 3H; H6α), 1.19 (d, J6,5 = 7.2 Hz, 3H; 
H6β), 0.72 (s, 9H; 3 x CH3 (β)), 0.69 (s, 9H; 3 x CH3 (α)), -0.04 (s, 3H; CH3), -0.06 (s, 3H; CH3), -
0.08 (s, 6H; 2 x CH3); 13C NMR (100 MHz, CD3CN): δ = 127.2, 127.3, 129.2, 129.4, 129.8, 130.0, 
139.8, 140.0 (-Arα, -Arβ), 105.3 (C1α), 98.9 (C1β), 93.4 (C7α), 93.1 (C7β), 81.7 (C2α), 79.6, 78.9 
(C3α, C3β), 77.2 (C2β), 78.4, 75.5 (C4α, C4β), 71.5 (C5α), 71.2 (C5β), 26.2, 26.1 (3 x CH3 (α), 3 x 
CH3 (β)), 16.6 (C6α), 16.3 (C6β), -4.9 (CH3), -4.8 (2 x CH3), -4.7 (CH3); m/z (ESI+ve): 389 ([M+Na]+, 
100%); HRMS (ESI+ve): found 389.1755 [M+Na]+; C19H30NaO5Si+ requires 389.1755. 
 
L-Quinovose [6-Deoxy-L-glucose] 12 
DOWEX® 50WX8-200 (H+ form) (100 mg) was added to a solution of lactol 30 (130 mg, 0.36 mmol) 
in water (5 mL). After stirring at rt for 15 h mass spectrometry indicated the completion of reaction, 
the resin was filtered off and water was removed in vacuo to yield 6-deoxy-L-glucose 12 as a syrup 
(α:β ratio 3:5) (58 mg, 100%).   
 [α]D20 = -40 (c = 1.39 in H2O) {lit. [30] [α]D20 = -27 (c = 2 in H2O), commercial sample of 6-deoxy-D-
glucose: [α]D20 = +27 (c = 2 in H2O)}; 1H NMR (400 MHz, D2O): δ = 5.10 (d, J1,2 = 3.8 Hz, 1H; H1α), 
4.55 (d, J1,2 = 7.9, 1H; H1β,), 3.85 (dq, J5,6 = 6.3 Hz, J5,4 = 9.6 Hz, 1H; H5α), 3.58 (t, J3,2 = J3,4 = 9.5 
Hz, 1H; H3α), 3.47 (dd, J2,1 = 3.8 Hz, J2,3 = 9.9 Hz, 1H; H2α), 3.42 (dq, J5,6 = 6.2 Hz, J5,4 = 9.5 Hz, 
1H; H5β), 3.36 (t, J3,2 = J3,4 = 9.3 Hz, 1H; H3β), 3.17 (dd, J2,1 = 7.9 Hz, J2,3 = 9.3 Hz, 1H; H2β), 3.08 (t, 
J4,3 = J4,5 = 9.3 Hz, 1H; H4β), 3.07 (t, J4,3 = J4,5 = 9.5 Hz, 1H; H4α), 1.21 (d, J6,5 = 6.1 Hz, 3H; H6β), 
1.19 (d, J6α,5α = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): δ = 96.9 (C1β), 93.2 (C1α), 76.7 (C3β), 
76.4 (C4α), 76.1 (C4β), 75.6 (C2β), 73.6 (C3α), 73.1 (C5β), 72.9 (C2α), 68.6 (C5α), 17.9 (C6α, C6β); 
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m/z (ESI+ve): 165 ([M+H]+, 100%); HRMS (ESI+ve): found 165.0757 [M+H]+; C6H13O5+ requires 
165.0757. 
 
3,5-O-Benzylidene-2,6-dideoxy-L-arabino-hexono-1,4-lactone 32 
Lithium iodide hydrate (917 mg, 4.91 mmol) was added to a solution of triflate 10 (300 mg, 0.79 
mmol) in butanone (10 mL). The reaction mixture was stirred at 60 °C for 16 h until TLC 
(cyclohexane/ethyl acetate, 1:1) showed the disappearance of starting material (Rf 0.57) and formation 
of one major product (Rf 0.39). Then sodium thiosulfate (sat. aq., sat, 10 mL) was added. After 
stirring at rt for 10 min, the reaction mixture was extracted with ethyl acetate (3 x 10 mL), the organic 
phase was dried (MgSO4) and the solvent was removed in vacuo to give a residue which was purified 
by flash chromatography (cyclohexane/ethyl acetate, 4:1→1:1) to obtain the deoxylactone 32 (137 mg, 
74%) as a white solid.  
m.p.: 100-102 °C; [α]D20 = -61.6 (c = 0.25 in MeOH); 1H NMR (400 MHz, CDCl3): δ = 7.49–7.38 (m, 
5H; -Ar), 5.8 (s, 1H; H7), 4.78 (br-dd, J3,4 = 3.7 Hz, J3,2’ = 4.6 Hz, 1H; H3), 4.48 (dq, J5,4 = 2.4 Hz, J5,6 
= 7.0 Hz, 1H; H5), 4.16 (br-dd, J4,3 = 3.7 Hz, J4,5 = 2.4 Hz, 1H; H4), 2.82 (dd, J2’,3 = 4.6 Hz, Jgem = 
17.7 Hz, 1H; H2’), 2.74 (d, Jgem = 17.6 Hz, 1H; H2), 1.53 (d, J6,5 = 7.0 Hz, 3H; H6); 13C NMR (100 
MHz, CDCl3): δ = 175.2 (C=O), 126.5, 128.7, 129.6, 137.8 (-Ar), 93.8 (C7), 79.1 (C4), 70.7 (C3), 
68.5 (C5), 37.5 (C2), 16.7 (C6); IR (thin film): vmax = 1780 (C=O); m/z (ESI+ve): 235 ([M+H]+, 
100%); HRMS (ESI+ve): found 298.0798 [M+Na]+; C13H13N3NaO4+ requires 298.0798. 
 
3,5-O-Benzylidene-2,6-dideoxy-L-arabino-hexose 33 
Diisobutylaluminium hydride (25% wt. in toluene, 0.32 mL, 0.56 mmol) was added dropwise to a 
solution of 32 (100 mg, 0.43 mmol) in anhydrous dichloromethane (4 mL) at -78 °C. The reaction 
mixture was stirred at -78 °C for 3 h until TLC (cyclohexane/ethyl acetate, 1:1) indicated the 
disappearance of starting material (Rf 0.42) and the formation of one product (Rf 0.49). Also mass 
spectrometry showed the formation of desired product peak (m/z 259). Then the mixture was diluted 
with ethyl acetate (5 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring 
for 5 h, the mixture was diluted with water (5 mL) and extracted with ethyl acetate (3 x 5 mL). The 
organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a residue that 
was further purified via flash chromatography (cyclohexane/ethyl acetate 5:1 to 1:1) to yield the 
benzylidene lactols 33 as a white solid (α:β ratio 10:1) (96 mg, 96%). 
m.p.: 90-92 °C; [α]D20 = -34 (c = 0.27 in MeOH); 1H NMR (400 MHz, CD3Cl): δ = 7.34-7.54 (m, 
10H; -Arα, -Arβ), 5.83 (t, J1,2 = J1,2’ = 4.7 Hz, 1H; H1α), 5.78 (s, 1H; H7β), 5.73 (s, 1H; H7α), 5.46 (d, 
J2,1 = 5.1 Hz, 1H; H1β), 4.61 (br-s, 2H; H3α, H3β), 4.54 (a-q, J5,6 = 7.0 Hz, 1H; H5β), 4.41 (a-q, J5,6 = 
7.0 Hz, 1H; H5α), 3.9 (br-s, 1H; H4α), 3.7 (br-s, 1H; H4β), 2.47 (dd, J2’,3 = 5.7 Hz, Jgem = 14.5 Hz, 
1H; H2α’), 2.28 (d, Jgem = 14.0 Hz, 1H; H2β’), 2.19 (dt, J2,1 = J2,3 = 4.7 Hz, Jgem = 14.0 Hz, 1H; H2β), 
2.12 (dt, J2,1 = J2,3 = 4.5 Hz, Jgem = 14.3 Hz, 1H; H2α), 1.50 (d, J6,5 = 7.0 Hz, 3H; H6β), 1.49 (d, J6,5 = 
7.0 Hz, 3H; H6α); 13C NMR (100 MHz, CDCl3): δ = 126.4, 126.5, 128.6, 128.7, 128.8, 129.2, 129.5, 
129.6 (-Arα, -Arβ), 99.6 (C1β), 98.7 (C1α), 93.3 (C7α, C7β), 79.5 (C4β), 77.5 (C4α), 74.8 (C3α), 
73.8 (C3β), 70.8 (C5β), 69.7 (C5α), 41.9 (C2α), 41.5 (C2β), 17.2 (C6α), 17.0 (C6β); m/z (ESI+ve): 
237 ([M+H]+, 100%); HRMS (ESI+ve): found 237.1118 [M+H]+; C13H17O4+ requires 237.1120. 
 
L-Olivose [2,6-Dideoxy-L-arabino-hexose] 13 
DOWEX® 50WX8-200 (H+ form) (100 mg) was added into a solution of lactol 33 (90 mg, 0.38 mmol) 
in water (5 mL). After stirring at rt for 18 h and mass spectrum indicated the completion of reaction, 
the resin was filtered off and water was removed in vacuo to yield L-olivose 13 as a syrup (α:β ratio 
1:1) (56 mg, 100%). 
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 [α]D20 = -13 (c = 0.49 in H2O) {lit.[32] [α]D20 = -20 (c = 0.80 in H2O)}; 1H NMR (400 MHz, D2O): δ = 
5.31 (a-dd, J1,2’ = 1.0 Hz, J1,2 = 3.7 Hz, 1H; H1α), 4.91 (dd, J1,2’ = 2.0 Hz, J1,2 = 9.8 Hz, 1H; H1β), 
3.91-3.83 (m, 2H; H3α, H5α), 3.66 (ddd, J3,2’ = 5.0 Hz, J3,4 = 9.0 Hz, J3,2 = 12.0 Hz, 1H; H3β), 3.41 
(dq, J5,6 = 6.3 Hz, J5,4 = 9.5 Hz, 1H; H5β), 3.10 (t, J4,3 = J4,5 = 9.3 Hz, 1H; H4α), 3.05 (t, J4,3 = J4,5 = 9.3 
Hz, 1H; H4β), 2.25 (ddd, J2’,1 = 2.0 Hz, J2’,3 = 5.0 Hz, Jgem = 12.3, 1H; H2β’), 2.13 (ddd, J2’,1 = 1.0 Hz, 
J2’,3 = 5.1 Hz, Jgem = 13.4 Hz, 1H; H2α’), 1.51 (dt, J2,1 = 9.9 Hz, J2,3 = Jgem = 12.0 Hz, 1H; H2β), 1.28 
(d, J6,5 = 6.3 Hz, 3H; H6β), 1.25 (d, J6,5 = 6.4 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): δ = 93.8 
(C1β), 91.7 (C1α), 77.4 (C4α), 76.8 (C4β), 72.5 (C5β), 70.7 (C3β), 68.5, 68.3 (C3α, C5α), 40.3 (C2β), 
38.2 (C2α), 17.5 (C6β, C6α); m/z (ESI+ve): 171 ([M+Na]+, 100%); HRMS (ESI+ve): found 149.0808 
[M+H]+; C6H13O4+ requires 149.0808.  
 
3,5-O-Benzylidene-2-azido-2,6-dideoxy-L-glucono-1,4-lactone 34 
Sodium azide (16.6 mg, 0.26 mmol) was added to a solution of triflate 10 (100 mg, 0.26 mmol) in 
anhydrous DMF. The mixture was stirred at -30 °C for 6 h until TLC (cyclohexane/ethyl acetate, 1:1) 
indicated the formation of the only product (Rf 0.68). After being diluted with ethyl acetate (5 mL), 
the mixture was washed with half saturated brine (10 mL). The organic phase was dried (MgSO4), 
filtered and solvent was removed in vacuo to obtain a crude solid that was purified via flash 
chromatography (cyclohexane/ethyl acetate 5:1) to yield the azido lactone 34 as a white solid (53.3 
mg, 75%).  
m.p.: 70-74 °C; [α]D20 = -150 (c = 0.89 in CHCl3); 1H NMR (400 MHz, CDCl3): δ = 7.39–7.46 (m, 
5H; -Ar), 5.8 (s, 1H; H7), 4.57 (dq, J5,4 = 1.8 Hz, J5,6 = 7.2 Hz, 1H; H5), 4.51 (d, J3,4 = 2.9 Hz, 1H; 
H3), 4.31 (t, J4,3 = J4,5 = 2.4 Hz, 1H; H4), 4.24 (s, 1H; H2), 1.54 (d, J6,5 = 7.2 Hz, 3H; H6); 13C NMR 
(100 MHz, CDCl3): δ = 171.3 (C=O), 137.2, 129.6, 128.8, 126.5 (-Ar), 93.4 (C7), 77.5 (C4), 73.7 
(C3), 68.7 (C5), 63.0 (C2), 16.0 (C6); IR (thin film): vmax = 2112 (s, N3); m/z (ESI+ve): 298 ([M + 
Na]+, 100%); HRMS (ESI+ve): found 298.0796 [M+Na]+; C12H19FNaO5+ requires 298.0798.  
 
3,5-O-Benzylidene-2-azido-2,6-dideoxy-L-glucose 35 
Diisobutylaluminium hydride (25% w/v in toluene, 0.34 mL, 0.60 mmol) was added dropwise to a 
solution of 34 (150 mg, 0.55 mmol) in anhydrous dichloromethane (5 mL) at -78 °C. The reaction 
mixture was stirred at -78 °C for 2 h until mass spectrometry showed the formation of desired product 
peak (m/z 300) and disappearance of starting material peak (m/z 298). Then the mixture was diluted with 
ethyl acetate (5 mL) and potassium sodium tartrate (sat. aq., ~0.5 mL) was added. After stirring for 5 
h, the mixture was diluted with water (5 mL) and extracted with ethyl acetate (3 x 5 mL). The organic 
phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a crude product that 
was further purified via flash chromatography (cyclohexane/ethyl acetate 7:1) to yield the benzylidene 
lactol 35 as a colourless oil (α:β ratio 5:4) (126 mg, 84%). 
 [α]D20 = -142 (c = 1.70 in MeOH); 1H NMR (400 MHz, CD3CN): δ = 7.25-7.14 (m, 10H; -Arα, -Arβ); 
5.59 (s, 1H; H7β), 5.52 (s, 1H; H7α), 5.46 (dd, J1,2 = 4.1 Hz, J1,OH = 6.7 Hz, 1H; H1β), 4.94 (d, J1,OH = 
9.5 Hz, 1H; H1α), 4.50 (d, JOH,1 = 6.9 Hz, 1H; OHβ), 4.32 (br-d, J3,2 = J3,4 = 2.7 Hz, 1H; H3β), 4.24 (t, 
J3,4 = J3,2 = 2.5 Hz, 1H; H3α), 4.14 (dq, J5,4 = 2.3 Hz, J5,6 = 7.0 Hz, 1H; H5β), 4.00 (dq, J5,4 = 2.6 Hz, 
J5,6 = 7.0 Hz, 1H; H5α), 4.00 (dq, J5,4 = 2.6 Hz, J5,6 = 7.0 Hz, 1H; H5α), 3.81-3.84 (m, 2H; H2α, H2β), 
3.67 (t, J4,3 = J4,5 = 2.7 Hz, 1H; H4α), 3.59 (t, J4,3 = J4,5 = 2.6 Hz, 1H; H4β), 1.21 (d, J6,5 = 7.0 Hz, 3H; 
H6β), 1.17 (d, J6,5 = 7.2 Hz, 3H; H6α); 13C NMR (100 MHz, CD3CN): δ = 126.2, 126.3, 128.3, 128.4, 
128.9, 129.1, 138.5, 138.8 (-Arα, -Arβ), 101.5 (C1α), 98.1 (C1β), 93.0 (C7β), 92.8 (C7α), 77.7 (C4β), 
77.1 (C3α), 76.2 (C3β), 75.6 (C4α), 70.1 (C5β), 69.7 (C5α), 70.2, 66.8 (C2α, C2β), 15.8, 15.6 (C6α, 
C6β); IR (thin film): vmax = 2110 (s, N3); m/z (ESI+ve): 300 ([M + Na]+, 100%); HRMS (ESI+ve): 
found 300.0905 [M+Na]+; C19H30NaO5Si+ requires 300.0905. 
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3,5-O-Benzylidene-2-azido-2, 6-dideoxy-L-mannono-1,4-lactone 36 
A) From the manno-triflate 10 
Sodium azide (260 mg, 4.0 mmol) was added to a solution of triflate 10 (1.5 g, 4.0 mmol) in 
anhydrous DMF at 0 °C. The mixture was stirred at 0 °C for 1.5 h after which it was stirred at room 
temperature overnight. After 12 hours TLC analysis (cyclohexane/ethyl acetate, 1:1) indicated the 
formation of the only product (Rf 0.38). The mixture was diluted with ethyl acetate (50 mL), washed 
with brine (50 mL), half saturated brine (50 mL) and then brine (50 mL) again. The organic phase was 
dried (MgSO4), filtered and reduced in vacuo to obtain a crude solid which was purified by flash 
column chromatography (cyclohexane/ethyl acetate 2:1→1:2) to afford the manno-azido 36 as a 
colourless solid (932 mg, 85%); none of the epimeric gluco-azide 34 was isolated under these 
conditions. 
B) From the gluco-triflate 11 
Triflic anhydride (1.11 mL, 6.5 mmol) was added dropwise to a solution of benzylidene lactone 28 
(800 mg, 3.2 mmol) and anhydrous pyridine (1.25 mL, 15.5 mmol) in anhydrous THF (10 mL) at -
20 °C. After stirring at -20 °C for 8 h, TLC (cyclohexane/ethyl acetate, 1:1) indicated the formation of 
one major product (Rf 0.70). The reaction mixture was diluted with DCM (10 mL) and washed with 
HCl (2 M, aq. 3 x 10 mL). The organic layer was dried (MgSO4) and the solvent was removed in 
vacuo to give the crude triflate 11 (1.3 g) which was not stable to chromatography and was used 
without further purification. 
Sodium azide (204.8 mg, 3.2 mmol) was added into a solution of the crude triflate 11 (1.3 g) in 
anhydrous DMF (20 mL). The mixture was stirred at -40 °C for 18 h until TLC (cyclohexane/ethyl 
acetate, 1:1) indicated the formation of one major product (Rf 0.42) and one minor product (Rf 0.68). 
After being diluted with ethyl acetate (20 mL), the mixture was washed with half saturated brine (20 
mL). The organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a 
crude that was further purified via flash chromatography (cyclohexane/ethyl acetate 5:1 to 1:1) to 
yield the azido lactone 36 as a white solid (616 mg, 70%) and 34 (211 mg, 24%).  
m.p.: 148 - 152 °C; [α]D20 = -70 (c = 0.52 in CHCl3); 1H NMR (400 MHz, CDCl3): δ = 7.49–7.38 (m, 
5H; -Ar), 5.9 (s, 1H; H7), 4.87 (dd, J3,4 = 2.1 Hz, J3,2 = 4.0 Hz, 1H; H3), 4.57 (br-dq, J5,4 = 1.7 Hz, J5,6 
= 7.3 Hz, 1H; H5), 4.12 (t, J4,3 = J4,5 = 1.7 Hz, 1H; H4), 4.04 (d, J2,3 = 4.1 Hz, 1H; H2), 1.56 (d, J6,5 = 
7.3 Hz, 3H; H6); 13C NMR (100 MHz, CDCl3): δ = 170.8 (C=O), 137.0, 129.7, 128.7, 126.5 (-Ar), 
93.0 (C7), 75.0 (C4), 72.5 (C3), 69.3 (C5), 62.0 (C2), 15.7 (C6); IR (thin film): vmax = 2109 (s, N3), 
1789 (C=O); m/z (ESI+ve): 298 ([M + H]+, 100%); HRMS (ESI+ve): found 298.0798 [M+Na]+; 
C12H19FNaO5+ requires 298.0798.  
 
3,5-O-Benzylidene-2-azido-2, 6-dideoxy-L-mannose 37 
Diisobutylaluminium hydride (25% w/v in toluene, 0.83 mL, 1.46 mmol) was added dropwise to a 
solution of 36 (310 mg, 1.13 mmol) in anhydrous dichloromethane (10 mL) at -78 °C. The reaction 
mixture was stirred at -78 °C for 3 h until TLC (cyclohexane/ethyl acetate, 1:1) indicated the 
consumption of starting material (Rf 0.42) and the formation of one product (Rf 0.50). Then the 
mixture was diluted with ethyl acetate (10 mL) and potassium sodium tartrate (sat. aq., ~1.0 mL) was 
added. After stirring for 5 h, the mixture was diluted with water (10 mL) and extracted with ethyl 
acetate (3 x 10 mL). Organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to 
obtain a crude that was further purified via flash chromatography (cyclohexane/ethyl acetate 3:1 to 
1:1) to yield the lactol 37 as a white solid (α:β ratio 2:1) (270 mg, 87%). 
 [α]D20 = -84 (c = 0.75 in CHCl3); 1H NMR (500 MHz, CDCl3): δ = 7.51-7.34 (m, 10H; -Arα, -Arβ), 
5.80 (s, 1H; H7α), 5.78 (s, 1H; H7β), 5.71 (d, J1,2 = 5.0 Hz, 1H; H1β), 5.38 (d, J1,2 = 4.7 Hz, 1H; H1α), 
4.69 (t, J3,2 = J3,4 = 3.2 Hz, 1H; H3α), 1.46 (d, J6,5 = 7.3 Hz, 3H; H6β), 4.62 (dd, J3,4 = 2.5 Hz, J3,2 = 4.1 
Hz, 1H; H3β), 4.46 (dq, J5,4 = 1.3 Hz, J5,6 = 7.3 Hz, 1H; H5α), 4.35 (dq, J5,4 = 1.6 Hz, J5,6 = 7.3 Hz, 
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1H; H5β), 4.03 (br-t, J4,3 = J4,5 = 1.8 Hz, 1H; H4β), 3.74 (dd, J2,1 = 4.1 Hz, J2,1 = 5.0 Hz, 1H; H2β), 
3.72 (br-t, J4,3 = J4,5 = 1.8 Hz, 1H; H4α), 3.64 (dd, J2,3 = 3.2 Hz, J2,1 = 4.7 Hz, 1H; H2α), 1.49 (d, J6,5 = 
7.3 Hz, 3H; H6α); 13C NMR (100 MHz, CDCl3): δ = 126.2, 126.5, 128.6, 128.8, 129.3, 129.5, 137.5, 
138.0 (-Arα, -Arβ), 100.6 (C1β), 98.3 (C1α), 93.2 (C7α, C7β), 77.0 (C4α, C4β), 74.8 (C3β), 74.1 
(C3α), 71.1 (C5α), 70.2 (C5β), 68.7 (C2β), 63.5 (C2α), 16.7 (C6α), 16.6 (C6β); IR (thin film): vmax = 
2110 (s, N3); m/z (ESI+ve): 300 ([M + Na]+, 100%); HRMS (ESI+ve): found 300.0901 [M+Na]+; 
C19H30NaO5Si+ requires 300.0905.  
 
2-Azido-2,6-dideoxy-L-glucose 38 
DOWEX® 50WX8-200 (H+ form) (100 mg) was added to a solution of the protected lactol 35 (100 mg, 
0.36 mmol) in water / 1,4-dioxane (1:1, 5 mL). After stirring at RT for 21 h, the mass spectrum 
indicated the completion of reaction; the resin was filtered off and water was removed in vacuo to 
yield the azide 38 as a light yellow syrup (α:β ratio 2:5) (67 mg, 99%). 
 [α]D20 = +1.6 (c = 0.80 in H2O); 1H NMR (400 MHz, D2O): δ = 5.29 (d, J1,2 = 3.7 Hz, 1H; H1α), 4.67 
(d, J1,2 = 8.1 Hz, 1H; H1β), 3.90 (dq, J5,6 = 6.3 Hz, J5,4 = 9.6 Hz, 1H; H5α), 3.79 (dd, J3,4 = 9.3 Hz, J3,2 
= 10.2 Hz, 1H; H3α), 3.47 (dq, J5,6 = 6.2 Hz, J5,4 = 9.5 Hz, 1H; H5β), 3.46 (dd, J2,1 = 3.4 Hz, J2,3 = 
10.3 Hz, 1H; H2α), 3.43 (t, J3,2 = J3,4 = 9.3 Hz, 1H; H3β), 3.27 (dd, J2,1 = 8.1 Hz, J2,3 = 9.9 Hz, 1H; 
H2β), 3.21 (t, J4,3 = J4,5 = 9.5 Hz, 1H; H4α), 3.20 (t, J4,3 = J4,5 = 9.3 Hz, 1H; H4β), 1.28 (d, J6,5 = 6.1 Hz, 
3H; H6β), 1.26 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): δ = 95.5 (C1β), 91.6 (C1α), 
75.9 (C4α), 75.4 (C4β), 74.6 (C3β), 72.6 (C5β), 71.6 (C3α), 68.2 (C5α), 67.7 (C2β), 64.4 (C2α), 17.3 
(C6α, C6β),; IR (thin film): vmax = 2110 (s, N3); m/z (ESI+ve): 212 ([M + Na]+, 100%); HRMS 
(ESI+ve): found 190.0820 [M+H]+; C6H13O5+ requires 190.0822. 
 
2-Amino-2,6-dideoxy-L-glucose hydrochloride 39 
10% Palladium on charcoal (10 % wt., 15 mg) and aqueous HCl (2M, 0.1 mL) was added to a 
solution of 38 (67 mg, 0.36 mmol) in water (3 mL). The reaction mixture was flushed with nitrogen, 
argon and hydrogen gas sequentially. The reaction mixture was stirred vigorously for 2 h at RT under 
hydrogen atmosphere until the completion of reaction was confirmed by mass spectrometry (m/z 
(ESI+ve): 164 [M+H]+). After filtration, the solvent was removed in vacuo to afford the HCl salt of 
39 as a brown gum (α:β ratio 1:1) (70 mg, 98%).  
 [α]D20 = -49.6 (c = 0.29 in H2O) {lit. [34] [α]D20 = -50 (c = 1.1 in H2O)}; 1H NMR (400 MHz, D2O): δ = 
5.38 (d, J1,2 = 3.5 Hz, 1H; H1α), 4.91 (d, J1,2 = 8.4 Hz, 1H; H1β), 3.95 (dq, J5,6 = 6.3 Hz, J5,4 = 9.6 Hz, 
1H; H5α), 3.82 (t, J3,2 = J3,4 = 9.7 Hz, 1H; H3α), 3.62 (t, J3,2 = J3,4 = 9.3 Hz, 1H; H3β), 3.54 (dq, J5,6 = 
6.2 Hz, J5,4 = 9.3, 1H; H5β), 3.30 (dd, J2,1 = 3.5 Hz, J2,3 = 10.7 Hz, 1H; H2α), 3.22 (t, J4,3 = J4,5 = 9.2 
Hz, 1H; H4β), 3.21 (t, J4,3 = J4,5 = 9.3 Hz, 1H; H4α), 3.00 (dd, J2,1 = 8.7 Hz, J2,3 = 10.4 Hz, 1H; H2β), 
1.30 (d, J6,5 = 6.1 Hz, 3H; H6β), 1.27 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): δ = 93.0 
(C1β), 89.5 (C1α), 75.6, 75.5 (C4α, C4β), 72.8 (C5β), 72.3 (C3β), 70.0 (C3α), 68.2 (C5α), 57.5 (C2β), 
55.1 (C2α), 17.2, 17.1 (C6α, C6β); m/z (ESI+ve): 164 ([M + H]+, 100%); HRMS (ESI+ve): found 
164.0916 [M+H]+; C6H14NO4+ requires 164.0917.  
 
3,5-O-Benzylidene-2-acetamido-2, 6-dideoxy-L-glucose 40 
10% Palladium on charcoal (10 % wt., 20 mg) and acetic anhydride (0.050 mL, 0.51 mmol) were 
added in a solution of lactol 35 (140 mg, 0.51 mmol) in ethyl acetate / 1,4-dioxane (2:1, 6 mL). The 
reaction mixture was flushed with nitrogen, argon and hydrogen gas sequentially. The reaction 
mixture was stirred vigorously for 4 h at rt under hydrogen atmosphere until TLC (ethyl 
acetate/methanol, 9:1) showed the disappearance of starting material (Rf 0.98) and the formation of 
the product (Rf 0.71). After filtration, the solvent was removed in vacuo to afford a residue that was 
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purified via flash chromatography (ethyl acetate / ethanol 15:1) to yield the protected azide 40 as a 
white solid (α:β ratio 3:1) (110.7 mg, 74%). 
m.p.: 131-133 °C; [α]D20 = +2.3 (c = 0.86 in MeOH); 1H NMR (400 MHz, CD3CN): δ = 7.50-7.38 
(10H, m, 1H; -Arα, -Arβ), 6.67 (2H, br-s, NHα and NHβ), 5.82 (1H, s, H7β), 5.75 (1H, s, H7α), 5.58 
(br-d, 1H, J1,2 = 3.8 Hz; H1α,), 5.11 (d, J1,2 = 9.8 Hz,, 1H; H1β), 4.84 (br-s, 2H; OHα and OHβ), 4.44 
(br-d, J3,2 = 2.9 Hz, 1H; H3β), 4.41 (m, 1H; H3α), 4.39 (dq, J5,4 = 1.7 Hz, J5,6 = 7.1 Hz, 1H; H5β), 
4.26-4.29 (m, 1H; H2α), 4.26 (dq, J5,4 = 2.9 Hz, J5,6 = 7.0 Hz, 1H; H5α), 4.11 (br-dd, J2,3 = 3.0 Hz, J2,1 
= 9.9 Hz, 1H; H2β), 3.88 (t, J4,3 = J4,5 = 3.1 Hz, 1H; H4α), 3.85 (t, J4,3 = J4,5 = 2.4 Hz, 1H; H4β), 1.91 
(s, 3H; CH3(β)), 1.91 (s, 3H; CH3(α)), 1.45 (d, J6,5 = 7.2 Hz, 3H; H6β), 1.41 (d, J6,5 = 7.0 Hz, 3H; 
H6α); 13C NMR (100 MHz, CD3CN): δ = 171.1 (C=O(α), C=O(β)), 127.1, 127.2, 129.2, 129.3, 129.8, 
130.0, 140.1 (-Arα, -Arβ), 103.2 (C1β), 96.2 (C1α), 94.1 (C7α), 93.8 (C7β), 79.5 (C3α), 78.5 (C3β), 
77.6 (C4β), 76.3 (C4α), 71.2 (C5β), 70.2 (C5α), 63.0 (C2β), 59.3 (C2α), 23.2 (CH3(α)), 23.0 (CH3(β)), 
17.1 (C6α), 16.9 (C6β); IR (thin film): vmax = 1673 (C=O); m/z (ESI+ve): 294 ([M + H]+, 100%); 
HRMS (ESI+ve): found 294.1335 [M+H]+; C15H20NO5+ requires 294.1336.  
 
2-Acetamido-2,6-dideoxy-L-glucose 41 
DOWEX® 50WX8-200 (H+ form) (100 mg) was added into a solution of 40 (110 mg, 0.38 mmol) in 
water / ethanol (1:1, 5 mL). After stirring at rt for 15 h, TLC (ethyl acetate/methanol, 9:1) indicated 
the disappearance of 40 (Rf 0.71) and the formation of a new spot (Rf 0.17). Then resin was filtered 
off and solvent was removed in vacuo to yield 41 as a white solid (α:β ratio 10:3) (69 mg, 90%).  
m.p.: 180-184 °C; [α]D20 = -53 (c = 0.22 in MeOH), [α]D20 = -48 (c = 1.0 in H2O) {lit. [34] m.p.: 201-
204, [α]D20 = -54 to -15 (initial to eqm, c = 1.0 in H2O)}; 1H NMR (500 MHz, CD3OD): δ = 5.06 (d, 
J1,2 = 3.5 Hz, 1H; H1α), 4.59 (d, J1,2 = 8.5 Hz, 1H; H1β), 3.91 (dq, J5,6 = 6.3 Hz, J5,4 = 9.1 Hz, 1H; 
H5α), 3.87 (dd, J2,1 = 3.5 Hz, J2,3 = 10.7 Hz, 1H; H2α), 3.68 (dd, J3,4 = 8.9 Hz, J3,2 = 10.7 Hz, 1H; 
H3α), 3.62 (dd, J2,1 = 8.5 Hz, J2,3 = 10.4 Hz, 1H; H2β), 3.42 (dd, J3,4 = 8.8 Hz, J3,2 = 10.4 Hz, 1H; H3β), 
3.34-3.38 (m, 1H; H5β), 3.07 (t, J4,3 = J4,5 = 8.8 Hz, 1H; H4β), 3.06 (t, J4,3 = J4,5 = 9.0 Hz, 1H; H4α), 
2.02 (s, 3H; CH3α), 2.02 (s, 3H; CH3β), 1.32 (d, J6,5 6.3 Hz, 3H; H6β), 1.26 (d, J6,5 6.3 Hz, 3H; H6α); 
13C NMR (100 MHz, CD3OD): δ = 172.8 (C=O(α)), 172.3 (C=O(β)), 95.4 (C1β), 91.0 (C1α), 76.8 
(C4α), 76.1 (C4β), 74.4 (C3β), 71.9 (C5β), 71.4 (C3α), 66.8 (C5α), 57.6 (C2β), 54.8 (C2α), 21.5 
(CH3α), 21.3 (CH3β), 16.9 (C6β), 16.8 (C6α); IR (thin film): vmax = 1633 (s, C=O); m/z (ESI+ve): 228 
([M + Na]+, 100%); HRMS (ESI+ve): found 228.0838 [M+Na]+; C8H15NNaO5+ requires 228.0842.  
 
2-Azido-2,6-dideoxy-L-mannose 42 
DOWEX@ 50WX8-200 (90 mg) was added into a solution of the protected rhamnono-azide 37 (47 mg, 
0.17 mmol) in water / 1,4-dioxane (1:1, 3 mL). After stirring at rt for 18 h, TLC (ethyl 
acetate/methanol 9:1) indicated the disappearance of 37 (Rf 0.50). Then resin was filtered off and 
solvent was removed in vacuo to yield the azide 42 as a light yellow gum (α:β ratio 7:10) (30 mg, 
95%). 
 [α]D20 = +9.4 (c = 0.30 in H2O); 1H NMR (400 MHz, D2O): δ = 5.20 (d, J1,2 = 1.1 Hz, 1H; H1α), 5.01 
(d, J1,2 = 1.1 Hz, 1H; H1β), 4.04 (a-dq, J2,1 = 1.1 Hz, J2,3 = 3.7 Hz, 1H; H2β), 3.99-4.02 (m, 2H; H2α, 
H3α), 3.87 (dq, J5,6 = 6.4 Hz, J5,4 = 9.6 Hz, 1H; H5α), 3.81 (dd, J3,2 = 3.8 Hz, J3,4 = 9.5 Hz, 1H; H3β), 
3.41 (dq, J5,6 = 6.3 Hz, J5,4 = 9.5 Hz, 1H; H5β), 3.40 (t, J4,3 = J4,5 = 9.6 Hz, 1H; H4α), 3.30 (t, J4,3 = J4,5 
= 9.5 Hz, 1H; H4β), 1.27 (d, J6,5 = 6.4 Hz, 3H; H6β), 1.25 (d, J6,5 = 6.8 Hz, 3H; H6α); 13C NMR (100 
MHz, D2O): δ = 93.4 (C1β), 92.7 (C1α), 72.9 (C4α, C3β, C5β), 72.4 (C4β), 70.5 (C3α), 68.9 (C5α), 
66.7 (C2β), 65.2 (C2α), 17.3, 17.2 (C6α, C6β); IR (thin film): vmax = 2106 (s, N3); m/z (ESI+ve): 212 
([M + Na]+, 100%); HRMS (ESI+ve): found 212.0641 [M+Na]+; C6H11NaO4+ requires 212.0642.   
 
2-Amino-2,6-dideoxy-L-mannose hydrochloride salt 43 
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10% Palladium on charcoal (10 % wt., 10 mg) and aqueous HCl (2 M, 0.1 mL) was added to a 
solution of the azide 42 (71 mg, 0.38 mmol) in H2O (5 mL). The reaction mixture was flushed with 
nitrogen, argon and hydrogen gas sequentially. The reaction mixture was stirred vigorously for 2 h at 
rt under hydrogen atmosphere until the completion of reaction was confirmed by mass spectrometry 
(m/z (ESI+ve): 164 [M+H]+). After filtration, the solvent was removed in vacuo to afford the HCl salt 
of 43 as an off white solid (α:β pyranose ratio 1:2) (75 mg, 99%). 
m.p.: 186-190 °C; [α]D20 = +21 (c = 0.26 in H2O) [lit. [34] m.p.: 170–175 °C (decomp), [α]D20 = +25.5 
(c = 0.4 in H2O)]; 1H NMR (400 MHz, D2O): δ = 5.32 (d, J1,2 = 1.2 Hz, 1H; H1α), 5.17 (d, J1,2 = 1.5 
Hz, 1H; H1β), 4.10 (dd, J3,2 = 4.7 Hz, J3,4 = 9.6 Hz, 1H; H3α), 3.97 (dq, J5,6 = 6.3 Hz, J5,4 = 9.6 Hz, 
1H; H5α), 3.92 (dd, J3,2 = 4.6 Hz, J3,4 = 9.6 Hz, 1H; H3β), 3.69 (dd, J2,1 = 1.2 Hz, J2,3 = 4.6 Hz, 1H; 
H2β), 3.63 (dd, J2,1 = 1.3 Hz, J4,5 = 4.6 Hz, 1H; H2α), 3.48 (dq, J5,6 = 6.1 Hz, J5,4 = 9.6 Hz, 1H; H5β), 
3.36 (t, J4,3 = J4,5 = 9.6 Hz, 1H; H4α), 3.31 (t, J4,3 = J4,5 = 9.6 Hz, 1H; H4β), 1.30 (d, J6,5 = 6.1 Hz, 3H; 
H6β), 1.28 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): δ = 91.3 (C1β), 90.8 (C1α), 72.8 
(C5β), 72.1 (C4α), 71.9 (C4β), 69.7 (C3β), 68.5 (C5α), 67.1 (C3α), 56.3 (C2β), 55.1 (C2α), 17.2, 17.1 
(C6α, C6β); m/z (ESI+ve): 164 ([M + H]+, 100%); HRMS (ESI+ve): found 164.0917 [M+H]+; 
C6H14NO4+ requires 164.0917. 
 
3,5-O-Benzylidene-2-acetamido-2, 6-dideoxy-L-mannose 44 
10% Palladium on charcoal (10 % wt., 20 mg) and acetic anhydride (0.043 mL, 0.43 mmol) were 
added in a solution of lactol 37 (120 mg, 0.43 mmol) in ethyl acetate / 1,4-dioxane (2:1, 6 mL). The 
reaction mixture was flushed with nitrogen, argon and hydrogen gas sequentially. The reaction 
mixture was stirred vigorously for 5 h at rt under hydrogen atmosphere until TLC (ethyl 
acetate/methanol 9:1) showed the disappearance of starting material (Rf 0.6) and the formation of the 
product (Rf 0.86). After filtration, the solvent was removed in vacuo to afford a residue that was 
purified via flash chromatography (ethyl acetate / ethanol 20:1) to yield the 44 as a white solid (α:β 
ratio 1:10) (110 mg, 88%). 
m.p.: 178-180 °C; [α]D20 = -26 (c = 0.82 in MeOH); 1H NMR (400 MHz, CD3OD): δ = 7.58 - 7.36 (m, 
10H; -Arα, -Arβ), 5.85 (s, 1H; H7α), 5.82 (s, 1H; H7β), 5.46 (d, J1,2 = 6.0 Hz, 1H; H1β), 5.33 (d, J1,2 = 
5.2 Hz, 1H; H1α), 4.58 (dd, J3,4 = 1.8 Hz, J3,2 = 4.1 Hz, 1H; H3β), 4.53-4.56 (m, 2H; H2α, H3α), 4.43 
(dd, J2,3 = 4.3 Hz, J2,1 = 6.0 Hz, 1H; H2β), 4.39-4.35 (m, 1H; H5α), 4.32 (q, J5,6 = 7.0 Hz, 1H; H5β), 
4.07 (br-s, 1H; H4β), 3.82 (t, J4,3 = J4,5 = 3.0 Hz, 1H; H4α), 2.03 (s, 3H; CH3(α)), 2.00 (s, 3H; CH3(β)), 
1.49 (d, J6,5 = 7.2 Hz, 3H; H6β), 1.46 (d, J6,5 = 7.0 Hz, 3H; H6α); 13C NMR (100 MHz, CD3OD): δ = 
174.6 (C=O(β)), 174.3 (C=O(α)), 128.4, 128.5, 129.9, 130.1, 130.7, 130.8, 140.7 (-Arα, -Arβ), 102.8 
(C1β), 97.6 (C1α), 95.9 (C7α), 94.3 (C7β), 79.6 (C4α), 78.2 (C4β), 75.4 (C3β), 74.5 (C3α), 72.7 
(C5β), 72.2 (C5α), 62.4 (C2β), 57.2 (C2α), 23.2 (CH3(α), CH3(β)), 17.8 (C6α), 17.0 (C6β); IR (thin 
film): vmax = 1653 (C=O); m/z (ESI+ve): 294 ([M + H]+, 100%); HRMS (ESI+ve): found 294.1330 
[M+H]+; C15H20NO5+ requires 294.1336. 
 
2-Acetamido-2, 6-dideoxy-L-mannose 45 
DOWEX® 50WX8-200 (H+ form) (90 mg) was added into a solution of 44 (90 mg, 0.31 mmol) in 
water / ethanol (1:1, 5 mL). After stirring at RT for 15 h, TLC (ethyl acetate/methanol 9:1) indicated 
the disappearance of 44 (Rf 0.86) and the formation of a new spot (Rf 0.17). Then resin was filtered 
off and solvent was removed in vacuo to yield 45 as a white solid (α:β pyranose ratio 5:2) (60 mg, 
98%). 
m.p.: 144-146 °C; [α]D20 = +8.9 (c = 0.36 in MeOH); 1H NMR (400 MHz, CD3OD): δ = 4.85 (d, J1,2 = 
1.1 Hz, 1H; H1α), 4.72 (d, J1,2 = 1.5 Hz, 1H; H1β), 4.31 (dd, J2,1 = 1.3 Hz, J2,3 4.4, 1H; H2β), 4.15 (dd, 
J2,1 = 1.4 Hz, J4,5 = 4.7 Hz, 1H; H2α), 3.86 (dd, J3,2 = 4.7 Hz, J3,4 = 9.6 Hz, 1H; H3α), 3.75 (dq, J5,6 = 
6.3 Hz, J5,4 = 9.3 Hz, 1H; H5β), 3.50 (dd, J3,2 = 4.6 Hz, J3,4 = 9.2 Hz, 1H; H3β), 3.22 (t, J4,3 = J4,5 = 9.6 
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Hz, 1H; H4α), 3.14-3.18 (m, 1H; H5α), 3.11 (t, J4,3 = J4,5 = 9.3 Hz, 1H; H4β), 1.96 (s, 3H; CH3α), 1.91 
(s, 3H; CH3β), 1.22 (d, J6,5 = 6.0 Hz, 3H; H6β), 1.17 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, 
CD3OD): δ = 175.5 (C=O(β)), 174.3 (C=O(α)), 95.0 (C1β), 94.8 (C1α), 74.4 (C4α), 74.2 (C4β), 74.0 
(C3β), 70.2 (C3α), 69.1 (C5β), 56.1 (C2β), 55.6 (C2α), 50.0 (C5α), 22.9 (CH3β), 22.7 (CH3α), 18.2 
(C6α), 18.1 (C6β); IR (thin film): vmax = 1636 (C=O); m/z (ESI+ve): 228 ([M + Na]+, 100%); HRMS 
(ESI+ve): found 228.0840 [M+H]+; C8H15NNaO5+ requires 228.0842.  
 
C 2-Deoxy-2-fluoro-L-rhamnose 16 and 2-Deoxy-2-fluoro-L-quinovose 17 from 3,4-di-O-acetyl 
rhamnal 
 
1, 3, 4-Tri-O-acetyl-2-fluoro-2, 6-dideoxy-β-L-mannose 46β 
Selectfluor (2.16 g, 6.1 mmol) was added to a solution of diacetyl rhamnal 15 (1.0 g, 4.6 mmol) in 
acetonitrile/water (40 mL, 3:1) at 0 °C. The reaction mixture was stirred at rt for 16 h until TLC 
(cyclohexane/ethyl acetate, 1:1) showed the disappearance of starting material (Rf 0.81). After 
removing solvent in vacuo, the mixture was dissolved into ethyl acetate (20 mL) and was washed with 
water (20 mL). Organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to 
obtain a residue (900 mg) which was dissolved into acetic anhydride/pyridine (20 mL, 1:1). The 
mixture was stirred for 6 h until TLC (hexane/ethyl acetate, 1:1) showed the formation of two major 
products (Rf 0.80, Rf 0.78). After removing solvent in vacuo, the residue was purified via flash 
chromatography (cyclohexane/ethyl acetate, 7:1) to yield 46β (400 mg, 30%) with minor impurities. 
A mixture of 46α and 47 (500 mg, 38%) was also isolated from chromatography. 46β was further 
purified by crystallization in ether to obtain pure 46β as a white solid (360 mg, 27%)  
m.p.: 124-126 °C; [α]D20 = -84 (c = 0.40 in MeOH); 1H NMR (400 MHz, CDCl3): δ = 6.21 (dd, J1,2 = 
2.2 Hz, J1,F = 7.0, 1H; H1), 5.22 (ddd, J3,2 = 2.6 Hz, J3,4  = 10.3 Hz, J3,F = 24.2 Hz, 1H; H3), 5.18 (ddd, 
J4,F = 2.0 Hz, J4,5 = 8.3 Hz, J4,3 = 10.3 Hz, 1H; H4), 4.75 (dt, J2,1 = J2,3 = 2.2 Hz, J2,F = 48.9 Hz, 1H; 
H2), 3.96 (dq, J5,6 = 6.4 Hz, J5,4 = 8.8 Hz, 1H; H5), 2.16 (s, 3H; CH3), 2.12 (s, 3H; CH3), 2.07 (s, 3H; 
CH3), 1.24 (d, J6,5 6.4 Hz, 3H; H6); 13C NMR (100 MHz, CDCl3): δ = 170.3 (C=O), 169.6 (C=O), 
168.3 (C=O), 90.1 (d, J1,F = 31 Hz; C1), 86.2 (d, J2,F = 180 Hz; C2), 70.2 (C4), 69.4 (d, J3,F 17 Hz; C3), 
68.8 (C5), 20.9 (CH3), 20.7 (CH3), 20.6 (CH3), 17.3 (C6); 19F NMR (376 MHz, CDCl3): δ = -203.6 
(dddd, JF,4 = 2.3 Hz, JF,1 = 7.0 Hz, J3,F = 26.0 Hz, J3,F = 48.0 Hz); IR (thin film): vmax = 1760, 1742 
(C=O); m/z (ESI+ve): 315 ([M+H]+, 100%); HRMS (ESI+ve): found 315.0851 [M+Na]+; 
C12H19FNaO5+ requires 315.0851.  
 
2,6-Dideoxy-2-fluoro-L-mannose (2-Deoxy-2-fluoro-L-rhamnose) 16 
Trifluoroacetic acid (1 mL) was added to a solution of 46β (170 mg) in water (2 mL). The mixture 
was stirred at 60 °C for 12 h until TLC (ethyl acetate/methanol 9:1) showed the disappearance of 
starting material (Rf 0.96) and the formation of one product (Rf 0.68). Solvent was removed in vacuo 
to obtain 2,6-dideoxy-2-fluoro-mannose 16 as a colorless syrup (α:β ratio 5:3) (96 mg, 100%). 
 [α]D20 = -3.5 (c = 0.91 in H2O); 1H NMR (400 MHz, D2O): δ = 5.30 (dd, J1,2 = 1.8 Hz, J1,F = 7.5 Hz, 
1H; H1α), 4.98 (d, J1,F = 20.5 Hz, 1H; H1β), 4.79 (dd, J2,3 = 2.5 Hz, J2,F = 51.2 Hz, 1H; H2β), 4.75 (dt, 
J2,3 = J2,1 = 2.2 Hz, J2,F = 49.3 Hz, 1H; H2α), 3.90-3.95 (m, 1H; H5α), 3.86 (ddd, J3,2 = 2.5 Hz, J3,4 = 
9.7 Hz, J3,F = 31.4 Hz, 1H; H3α), 4.72 (ddd, J3,2 = 2.6 Hz, J3,4 = 9.5 Hz, J3,F = 30.8 Hz, 1H; H3β), 
3.43-3.50 (m, 1H; H5β), 3.45 (t, J4,3 = J4,5 = 9.7 Hz, 1H; H4α), 3.40 (dt, J4,F = 1.0 Hz, J4,3 = J4,5 = 9.5 
Hz, 1H; H4β), 1.31 (d, J6,5 = 6.1 Hz, 3H; H6β), 1.29 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, 
D2O): δ = 92.7 (C1β, d, J1,F = 16 Hz), 92.1 (C2β, d, J2,F = 179 Hz), 91.8 (C1α, d, J1,F = 45 Hz), 91.1 
(C2α, d, J2,F = 171 Hz), 72.8 (C4α), 72.6 (C5β), 72.4 (C4β), 72.1 (C3β, d, J3,F = 18 Hz), 69.7 (C3α, d, 
J3,F = 18 Hz), 68.9 (C5α), 17.2 (C6α, C6β); 19F NMR (376 MHz, D2O): δ = -204.5 (ddd, JF,1 = 7.0 Hz, 
JF,3 = 32.0 Hz, JF,2 = 49.2 Hz), -223.0 (ddd, JF,1 = 20.6 Hz, JF,3 = 30.9 Hz, JF,2 = 51.5 Hz); m/z 
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(ESI+ve): 189 ([M + Na]+, 100%); HRMS (ESI+ve): found 189.0532 [M+Na]+; C6H11FNaO4+ 
requires 189.0534. 
 
2,6-Dideoxy-2-fluoro-L-glucose (2-Deoxy-2-fluoro-L-quinovose) 17 
Trifluoroacetic acid (2.5 mL) was added to a solution of the mixture of 46α and 47α/β (200 mg, 
obtained from the preparation of 46β) in water (2.5 mL). The mixture was stirred at 60 °C for 12 h 
until mass spectrum showed the completion of the reaction. After removing solvent in vacuo, 17 (5.2 
mg) was purified from the mixture (94 mg, containing 16 and 17) via HPLC. 
[α]D20 -38 (c 0.26, H2O) {lit. [32] [α]D20 -35 (c 0.27, H2O)}; 1H NMR (400 MHz, D2O): δ = 5.38 (d, J1,2 
= 4.0 Hz, 1H; H1α), 4.87 (dd, J1,F = 2.5 Hz, J1,2 = 7.9 Hz, 1H; H1β), 4.42 (ddd, J2,1 = 4.0 Hz, J2,3 = 9.5 
Hz, J2,F = 49.3 Hz, 1H; H2α), 4.09 (ddd, J2,1 = 7.9 Hz, J2,3 = 9.2 Hz, J2,F = 51.5 Hz, 1H; H2β), 3.91 (dq, 
J5,6 = 6.3 Hz, J5,4 = 9.5 Hz, 1H; H5α), 3.90 (ddd, J3,4 = 9.3 Hz, J3,2 = 9.5 Hz, J3,F = 13.3 Hz, 1H; H3α), 
3.73 (td, J3,4 = J3,2 = 9.2 Hz, J3,F = 15.1 Hz, 1H; H3β), 3.52 (dq, J5,6 = 6.3 Hz, J5,4 = 9.6 Hz, 1H; H5β), 
3.21 (dd, J4,3 = 9.2 Hz, J4,5 = 9.6 Hz, 1H; H4β), 3.19 (dd, J4,3 = 9.3 Hz, J4,5 = 9.5 Hz, 1H; H4α), 1.28 
(d, J6,5 = 6.3 Hz, 3H; H6β), 1.25 (d, J6,5 = 6.3 Hz, 3H; H6α); 13C NMR (100 MHz, D2O): 92.5 (d, J1,F 
23.5 Hz; C1β), 92.4 (d, J2,F 182.8 Hz; C2β), 89.7 (d, J2,F 185.6 Hz; C2α), 88.7 (d, J1,F 21.3 Hz; C1α), 
73.9 (d, J4,F 7.9 Hz; H4α), 73.8 (d, J4,F 7.9 Hz; H4β), 73.0 (d, J3,F 17 Hz; H3β), 71.3 (d, J5,F 1.3 Hz; 
C5β), 70.1 (d, J3,F 17 Hz; C3α), 66.5 (d, J5,F 1.2 Hz; C5α), 15.7 (C6α, C6β); 19F NMR (376 MHz, 
D2O): δ = -199.4 -199.0 (m, Fα and Fβ); m/z (ESI+ve): 189 ([M + Na]+, 100%). 
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